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Introduction & Background 
 
Environmental pollutants are a diverse class of chemicals that 
occur across all layers of the food web due to their high lipophilicity 
and unique chemistry. As per the United Nations Stockholm 
Convention on environmental pollutants, they can be classified as 
agricultural and industrial chemicals, or, in a formal way, as 
intentional and unintentional pollutants.  
Polychlorinated Biphenyls (PCBs) are a group of about two 
hundred and ten chemicals with a common biphenyl nucleus and 
varying number of chlorine substitutions in this nucleus. These 210 
compounds are classified based on number of chlorine 
substitutions as monochlorobiphenyls, dichlorobiphenyls, trichlorobi
phenyls, tetrachlorobiphenyls,  pentachlorobiphenyls, hexachlorobiph
enyls, heptachlorobiphenyls, octachlorobiphenyls, nonachlorobiphen
yls and decachlorobiphenyls, all ten classes also called PCB 
homologs. In each homolog or family of PCBs exist one to multiple 
congeners which may vary in the position of chlorine substitutions on 
the biphenyls nucleus – an aromatic two ringed structure, each 
congener can have many isomers and metabolites.  
Due to their halogenated nature and high lipophilicity, they 
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persist in the environment, bioaccumulate, biomagnify and cause 
tissue level effects across all levels of the food chain. Most PCB 
congeners can have environmental life lives ranging from 2 months 
to up to eight years or more depending on lipophilicity which 
determines the octanol : water partition coefficient (Kow) and hence, 
the biomagnifiable factor. For example, PCB 180 which is a more 
chlorinated and lipid soluble than the PCB 77 has higher Kow which 
makes it more persistent in the environment, especially in aquatic 
food web, but not restricted to it. This is because higher organisms 
including human beings and other carnivorous and omnivorous 
organism can be exposed to PCBs from fishes and other sources of 
foodstuff consumption. Of point to note is the fact that higher up the 
food chain, the toxicity and toxicokinetics are magnified many a fold 
compared to fishes and other fresh water aquatic and amphibian 
organisms.  
Their commercial mixtures whose large scale industrial 
production once occurred between 1930-1970s in US, Japan, and EU, 
their persistence led to their restriction and ban in these developed 
countries. These commercial mixtures are called Aroclors, Kaneclors, 
etc. in different countries, and are used only for limited indications 
now. There are twelve different Aroclors currently manufactured – 
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differing in their chlorine content, as indicated by the last two of the 
four-digit nomenclature of these complex chemical mixtures. This 
percentage is varied so that the physicochemical properties and hence 
the utility of these mixtures differ – for example, Aroclor 1232 
contains a biphenyl nucleus (12) and 32 % chlorine by molar mass, 
rendering to it favorable hydraulic, viscosity and semi-volatile 
characteristics. This is because of its high content (83%) of low 
chlorinated (<4n), ortho substituted, non-coplanar PCBs and co-
planar dioxin like PCBs in moderate amounts. PCBs congeners which 
possess coplanarity, ortho and meta substituted chlorines atoms and 
cause neuroendocrine disruption like dioxins i.e., by binding to aryl 
hydrocarbon receptors, are called dioxin like PCBs, e.g. PCB 77 and 
eleven other congeners exist. The nature of such dioxin like PCBs 
can be categorized as antiestrogenic, estrogenic or androgenic 
disruptions, which further add to the toxicodynamic complexity of 
PCBs.  
The Polychlorinated Biphenyls (PCBs) are a heterogenous 
class of organic compounds consisting of about 208-210 congeners 
that are grouped into ten homologs families based on the number of 
chlorine substitutions (ATSDR, 2000). They are classified as 
pollutants and regulated in a harmonized manner by the United 
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Nations Environment Protection Fund (UNEP) under the three 
conventions – The Rotterdam, Basel and Stockholm Conventions. 
Although tightly restricted in production and use under these 
Conventions under Annexes I and III, they are still used as industrial 
chemicals due to a poor scope of enforcement of their strict 
regulation in India (UNEP, 2017). This is because of their favourable 
hydraulic, dielectric, thermal, and persistent properties due to which 
their replacement in industries like electronics and rubber 
manufacturing units are not practical to be enforced. The United 
Nations Environment Program (UNEP) owns and executes three 
conventions for regulation and harmonization of pollutants and 
environmental intoxicants of which India is a member country. The 
Conventions viz., Basel, Rotterdam and Stockholm hold regular 
meetings and periodical reviews for assessing the risk and managing 
the sources of hazard of such chemicals. The Basel Convention 
regulates Persistent Organic Pollutants (POPs), whereas, the 
Rotterdam Convention harmonizes the Best Environment Practices 
(BEP) for complete and proper disposal, and enacting and enforcing 
alternatives to chemicals produced from electronic manufacturers and 
consumers. The Stockholm Convention harmonizes and gives 
recommendations for limiting or even ban of use and production of 
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industrial and agricultural pollutants. It classifies such chemicals as 
three Annexes – annex I chemicals (e.g. pesticides) are to be strictly 
banned as their use is intentional; Annex II (e.g. industrial chemicals) 
are to be restricted in use and production as their utility is intentional 
but required in certain situations, and Annex III (Agricultural and 
industrial chemicals) are to be reduced in use and proper disposal 
must be ensured as their use is unintentional and can be impractical to 
completely dispose of these chemicals. PCBs are uniquely placed 
under this UNEP classification as both intentional and unintentional 
industrial pollutants in both Annex I and III. Laws regulating their 
use are less stringent in India, although their production is banned or 
restricted in certain developed countries. 
The main source of PCBs as pollutants is their use as 
transformer and capacitor oils for their inertness to fire and dielectric 
properties. Additionally, they have also been used as additives in 
paints and other such preparations as plasticizers due to their 
favorable fluid nature and hydraulic properties. Due to their thermal 
inertness, they are also being employed in rubber industry. For 
example, Aroclor 1232 has been an additive in rubber, plastic and 
hydraulic industries, due to its viscosity and dielectric properties. 
Since these chemicals are highly lipophilic and chlorinated, 
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they bioaccumulate, persist and bio magnify in the environment. 
These processes occur across all levels of the food chain and is 
ubiquitously observed in the food web.  Due to these reasons, they 
getselectively magnified in certain species like marine fishes and get 
transferred to the next level of the food chain when these fished are 
consumed. Additionally, certain PCBs also magnify in humans after 
transmission via dermal and inhalational routes, the latter being more 
relevant for occupational exposures of workers as workplace hazard 
risk. 
Although strict regulations are in place in many developed 
countries for restriction of and even banning of the production and / 
or use of these chlorinated biphenyls from certain industrial sectors, 
the legal and regulatory status of these PCBs in India has not been 
promising so far, though India is a member of UNEP Stockholm 
Convention. 
In our study, we have assessed and evaluated the 
neurobehavioral toxicities of these pollutants on inhalational 
exposures in Swiss albino mice at different dose levels using an 
inhalational chamber. 
We selected Aroclor 1232 for dosing as it is a commercial PCB 
mixture that is unique among other such mixtures in that it is semi-
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volatile and contains high concentrations of low chlorinated ortho-
substituted PCBs that are hypothesized to be neurotoxic. In the study, 
after dosing of Aroclor 1232, the levels of PCB 77 (a dioxin like low 
chlorinated less lipophilic ortho substituted biphenyl) and PCB 180 (a 
highly lipophilic persistent organic pollutant) have been evaluated in 
biological matrices like brain and plasma.  
To meet the study objectives, swiss albino mice were exposed 
to different geometrically progressive doses of Aroclor 1232 in an 
inhalation chamber as per Organization for Economic Co-operation 
& Development (OECD, EU) guidelines for toxicity testing in an 
occupational risk assessment protocol. In this risk assessment 
protocol, the mice were exposed to the complex PCB mixture for 6 
hours a day over 5 days of a week for two weeks as a part of sub-
acute toxicity after acute toxicity assessments were completed.    
 
Figure 1: Chemical structure of PCB 77 (A) and PCB 180 (B). 
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Aim & Objectives 
2.1 . AIM: 
To elucidate the various neurobehavioral toxicities of PCB77 and 
PCB 180 in mice exposed to Aroclor 1232 via inhalational route at 
different doses.  
2.2 . OBJECTIVES: 
i. To characterize the neurobehavioral functions of mice 
exposed to PCB mixture via inhalational chamber across 
different dose levels 
ii. To estimate the pharmacokinetic and toxicokinetic 
parameters of PCB 77 and PCB 180 from the concentration-
time profiles across different dose levels in mouse brain and 
plasma 
iii. To evaluate the structural effects of PCB treatment on 
histopathological parameters of mouse central nervous 
system using immunohistochemical markers 
iv. To assess the penetrability of PCBs across the transplacental 
and translactational routes using behavioral scores as 
surrogate markers of one generation toxicity 
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Review of Literature 
3.1. THE STUDY COMPOUNDS  
3.1.1. Aroclor 1232, PCB 77 and PCB 180: physicochemical & 
toxicological characteristics: 
Aroclor 1232 is a Poly Chlorinated Biphenyl (PCB) mixture 
with 32 % chlorine by mass (US-EPA, ATSDR, 1989). The 
percentage of low chlorinated PCBs in this commercial mixture is 
about 75-80% by molar mass, although this variation is by lot of the 
Aroclor manufactured.  
 
Figure 2: Aroclor – generic chemical structure 
A unique feature of this Aroclor is that it is semi-volatile 
(vapour pressure = 0.00406 mm Hg at 25°C) and a predominantly air 
pollutant, although it can pollute water and get leached in soil. 
Additionally, it also contains high percentage of neurotoxic coplanar, 
ortho-substituted PCBs like PCB 180 and PCB 153, but less of 
endocrine disruptors like PCB 77 (ATSDR, 2000). It has a molecular 
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weight of 1100 Da and satisfies the bioconcentration criteria of BCF 
(Bioconcentration Factor) > 5000 and Log Kow of 5.1.  
Chemically, dioxin like PCBs are thought to have at least 3 out 
of 4 essential characteristics – meta-, para- and ortho- chlorine 
substitutions, coplanarity of the biphenyl nucleus and chlorination of 
the compound (ATSDR, 2000). PCB 77 is one such dioxin like but 
low chlorinated congener with a tetrachlorobiphenyl nucleus except 
that it does not have ortho substitution. Though it accumulates slowly 
in vivo (Bio accumulative potential in humans = 0.06), it is highly 
persistent (Human half-life = 0.33 years, with 12 Kg fat) and highly 
toxic (WHO TEF = 0.0001, WHO TEQ = 0.0017) endocrine disruptor 
(Isamu Ogura, 2004; Meghan O’grady, et al, 2009; Van Der Berg, 
2006). As it is low chlorinated with low molecular mass (MW = 292), 
it is semi-volatile – has a rat tissue half-life of 1.2 days only 
(Clevenger MA, et al., 1989). But it forms more of hydroxylated polar 
metabolites which is essentially neurotoxic, all of which are 
conjugated and eliminated by renal and hepatobiliary routes – hence, 
apparent half-life may be much longer. Moreover, due to higher 
substitutions of chlorine at para and meta positions, it is less 
susceptible to photodegradation and is highly neurotoxic (JiyanLiu et 
al., 2008; Katryn Eske, 2014). As it possesses a small dihedral angle 
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of  37°C, it is planar without ortho-substitution – hence, it chemically 
qualifies to be a dioxin like endocrine disrupting chemical (Samuel S, 
et al., 2010). Additionally it is a neuro-endocrine disruptor – apart 
from increasing dopamine and modulating serotonin, it has both 
estrogenic and anti-estrogenic actions – a unique feature among PCBs; 
hence, it can increase mother-litter interaction and litter size in 
rodents, but by reducing pup survival (Martha León-Olea, et al., 2014; 
Jurgen Hany, 1999). Of important uniqueness among low chlorinated 
congeners is the fact that PCB 77 is highly hydrophobic, with a Log 
Kow of 6.36 and gets absorbed to a lesser degree from the GIT (GIT 
absorption coefficient = 0.99), implying high persistence and 
lipophilicity. Also, it is unique among dioxin like PCBs to non ortho 
substituted – making it to possess less affinity to adipocytes though 
being more lipophilic. It also induces liver enzymes leading to 
interactions,then redistributes to adipocytes and blood serum equally, 
but this never reaches a steady state as distribution ratio in adipocyte 
vs. serum is greater than 1 (Isamu Ogura, 2004). Also, its adipocyte 
concentrations depend on body fat, and it causes adipocyte 
differentiation and redistribution causing obesity; is also orexigenic 
and leads to atherosclerosis (Violeta Arsenescu, et al., 2008). Since 
PCB 77 is a dioxin like congener, it has high affinity to bind to AhR in 
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the nucleus and this may be responsible for its neuro endocrine effects 
in vivo (Van der berg, 2006). Additionally, it impairs glucose 
homeostasis by its pro-inflammatory effects and is highly hepatotoxic 
(Somiranjan Ghosh, 2010; Nicki A. Baker, et al., 2013). This 
congener is highly carcinogenic and mutagenic due to its pro-
apoptotic effects (Stephen Safe, et al., 1992). Lastly, this PCB induces 
CYP1A family of xenobiotic metabolizing enzymes in a fashion like 
nicotine (ATSDR, 2000) and leads to xenobiotic interactions after 
environmental exposures. 
PCB 180 on the other hand, although possesses some properties 
of dioxin like congeners, is not a dioxin like PCB, and does not bind 
to AhR to produce endocrine disruption; does not have a WHO-TEF / 
TEQ value (Viluksela M, et al., 2014). It is a heptachlorobiphenyl is 
highly chlorinated and hence persistent in lipids (ATSDR, 2000). 
Also, this is highly lipophilic congener with a Log Kow of 7.36 and a 
food fugacity ratio of 2.45, which magnifies it in food consumed 
orally (John W. Nichols, et al., 2003). Paradoxically, it prefers serum 
to fat as it has an adipocyte to serum partition coefficient (K-fp) of 
2.41; may not redistribute like PCB 77 (Mattias Oberg, et al., 2002).  
The parent PCB 180 and its mono-hydroxyl metabolite displace 
thyroxine from the receptor sites causing hypothyroidism (Al-Anati L, 
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et al., 2015). With reference to p53 tumor suppressor gene, it has twin-
pronged effects – it promotes p53 translocation (basis for anti-
apoptotic effects unlike many other non-dioxin like congeners) but at 
the same time supresses its activity by signalling many tyrosine kinase 
cascades upstream (basis for DNA damage pathway activation, 
especially in female rodents) in liver (Al-Anati L, et al., 2010; Al-
Anati L, et al, 2015). It has a long elimination half-life and 
environmental fate – it has an intrinsic half-life of 11.5 years and an 
apparent biological half-life of 7-9 years. Unlike PCB 77 induced 
CYP1A effects, PCB 180 induces CYP2A and UGT superfamily of 
enzymes causing therapeutic interactions and epigenetic inborn errors 
of metabolism. Additionally, it also induces nuclear receptors like 
CAR, and PXR leading to alteration of transcription processes in the 
genome (Roland Ritter, et al., 2011). It is known to exert initially 
anorectic effects that are dose-dependent and also exerts pro-
inflammatory actions by increasing TNF-α, IL6 and other adipokines 
in the periphery and impairing leptin signalling. In the brain, it 
increases oxidative stress and motor activity without changing 
dopamine levels (Johanssen, et al., 2011).   
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3.2. EVIDENCE BASED NEURO-TOXICOLOGY OF PCBs 
3.2.1. Toxic effects of PCBs on neuronal systems:  
They are known to cause carcinogenic and mutagenic toxicities 
in established models like Salmonella microsome test (McCann, et al., 
1975). Although less thoroughly evaluated and published, PCBs are 
not devoid of neurotoxic albeit less well characterized effects. The 
PCB mixtures with higher chlorine content are more neurotoxic – 
Aroclor 1248 causes higher deficits in spatial alternation than Aroclor 
1016 in monkeys (Levin ED, et al., 1988). This was noted after 
feeding monkeys with 2.5 ppm of these PCB mixtures and assessing 
the spatial learning and memory using a chronic dietary intake 
protocol. Such disruptive effects on spatial memory and learning tasks 
are not restricted to spatial alternation, but also to spatial 
discrimination mimicking lesion models in Rhesus monkeys treated 
with PCBs – showed frontal cortical dysfunction and delays in spatial 
tasks (Levin ED, et al., 1992). Low chlorinated and coplanar 
congeners of high chlorinated Aroclors like Aroclor 1248 also reduced 
Long Term Potentiation (LTP) and in higher concentration affected 
synaptic transmission in CA 1 of hippocampus in rats treated with 
PCBs (Niemi WD, et al., 1998). This was also confirmed in vitro 
using hippocampal slices using field potentials and treatment with 
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Aroclor 1254, as noted by a failure to maintain the dendritic response 
to electrical post-tetanic train of stimulation after PCB treatment 
(Gilbert ME, et al., 1998). Such changes in LTP form basis for 
alterations in calcium homeostasis, protein kinase C changes and other 
cognitive alternations in response to PCB and aroclor treatment. 
Perinatal transfer of these persistent pollutants has similar 
effects on neurotransmitter pathways in the next generation – for 
example, dietary exposure of low dose (1.25 ppm) PCB mixture 
(Aroclor 1254) in fifteen day old pregnant and lactating rats increased 
the enzymatic activities Choline Acetyl Transferase (ChAT) in the rat 
forebrains. This increase in Acetylcholine neurotransmitter synthesis 
in the rat forebrains was both age (ChAT levels were reduced in 30-
day old animals) and dose dependant (Provost TL, et al., 1999). 
Additionally, this study also proved the effects of PCB mixtures on 
thyroid hormone profiles – Aroclor 1.25 and 2.5 ppm increased 
thyroxine levels in maternal matrices – whereas 2.5 ppm dietary 
Aroclor 1254 decreased its levels in pups. However, PCBs did not 
have any effects on tri-iodothyronine levels in rats fed with Aroclor 
1254 at any of the two doses. This study results were further proven in 
other studies assessing the effects of dietary PCBs on disruption of 
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brain ontogeny by affecting long term potentiation – especially the 
hippocampal LTP (Gilbert ME, et al., 1999).  
Similarly, PCBs are not devoid of adverse effects on 
instrumental learning paradigms; for instance, Aroclor 1254 treated 
male rats in the perinatal period exhibited errors in reference and 
working spatial memory which were sex specific (Roegge CS, et al., 
2000). Similarly, PCBs when given perinatally have reduced response 
rates in controlled scheduled behavioural paradigms in rodents (Taylor 
MM, et al., 2002). These findings suggest that other neurotransmitters 
like glutamate may also play a role in the neurobehavioral toxicities of 
PCBs.  
Though the effects of PCBs and their commercial mixtures on 
neurotransmitter systems have been documented, their effects on 
certain other neurotransmitters, especially diffuse systems have been 
controversial. For example, the oral treatment of pregnant Long Evans 
rats with Aroclor 1254 and Aroclor 1016 have had no effects on 
catecholamine levels or delayed spatial alternations, as reported by 
Zahalka EA, et al., 2001.  Not all toxicities are equally noted in both 
sexes of rodents treated with ortho-substituted PCBs – for such PCB 
congeners, higher toxicities are apparently observed in female sex 
compared to male counterparts, indicating role for hypothalamic 
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neurones for the sexually dimorphic behaviours (Bernard Weiss, 
2002). Apart from in utero exposures, certain PCB congeners which 
are highly basic and lipophilic can have toxic neurobehavioral effects 
in lactating offsprings vide secretion thorough breast milk. Early life 
psychomotor development and later life cognitive indices were 
reduced by this important route due to exposure particularly to 6 
mono-ortho substituted PCBs and 20 di-ortho substituted PCBs all of 
which are coplanar in nature compared to 4 non- planar PCBs (Susan 
L. Schantz, et al., 2003).  On the other side of the coin, a two-hit 
exposure to Aroclor 1221 prenatally and during juvenile development 
led to neuro-molecular toxicities (altered neuro hormones, DNA 
methylation and genetic / epigenetic effects) more in male Sprague 
Dawley rats than in female rats (Bell MR, et al., 2016). Aroclor 1221 
is low chlorinated PCB mixture with more ortho-substituted non-
planar PCBs. Hydroxylated metabolites of PCBs can induce 
competitions with transthyretin for binding with thyroxine which lead 
to alterations in the concentrations of thyroid hormones leading to 
neurodevelopmental effects (Courtney D. Sandau, et al., 2002). In 
addition, PCB 77 and Aroclor 1254 are known to interfere with 
deiodination of endogenous thyroxine in neuronal tissues during 
development disrupting neuronal growth and synaptogenesis, and 
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reducing biliary excretion of thyroid hormones (Kembra L. 
Howdeshell, 2002).  
PCBs like PCB 126 which is a dioxin like congener, causes 
endothelial dysfunction and proinflammatory response which could 
lead to some of the detrimental peripheral cardiovascular toxicities of 
PCBs.   
3.2.2. Mechanisms of neurotoxic effects of PCBs:  
The molecular effects of PCBs on neuronal architecture have 
also been well documented in the published literature. Chlorination of 
ortho-position of PCBs leads to increase in protein kinase C activity 
in-vitro in neurones (Youn Ju Lee et al., 2012). This PKC pathway is 
thought to modulate motor and cognitive pathways, though this 
modulation is species-specific. Furthermore, the isoforms of PKC viz., 
PKC-ε and PKC-α are known to mediate neuronal molecular pathways 
regulating long term potentiation, neuronal growth and differentiation. 
Such ortho-PCBs can reduce the expression and activity of antioxidant 
molecules like Glutathione (GSH) and increase the activities of 
catalase and superoxide dismutase inducing oxidative stress (Ezdihar 
A. Hassoun et al., 2010). This oxidative stress induced by PCB 126 in 
rats in this study follows a dose dependent pattern. On the other hand, 
a third molecular pathway influenced by dioxin like coplanar PCBs 
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like PCB 77 can lead to endocrine disruption through activation of 
cytosolic aryl hydrocarbon receptors (AhRs) in neuroendocrine cells 
(Anne-Simone Parent, et al., 2011). This activation is the basis for 
certain PCBs to exhibit estrogenic actions, certain other PCBs to exert 
antiestrogenic and pro-androgenic activities. Oestrogen receptor alpha 
induction by estrogenic PCBs early in adolescence can induce 
premature LH surge leading to infertility and other sexual effects 
(Micevych et al., 2010).  Induction of AhR can also lead to neuronal 
apoptosis by non-coplanar PCBs and alteration of glucose homeostasis 
through altered expression of erythroid-2-related factor in adipocytes, 
which seems to be reversed by resverterol by PCB 77 (Nicki A. Baker, 
et al., 2013). A fourth pathway influenced by NDL-PCBs like PCB 95 
lead to altered synaptogenesis is the ryanodine-calcium pathway in 
neurones through microRNA 132 (Adam Lesiak, et al., 2014). PCB 95 
stabilizes open configuration of RyR channels in dendrites by 
inducing favourable calcium oscillations and downstream changes in 
proteins like CREB, leading to increase in outgrowth of dendrites. 
PCBs also induce and activate nuclear receptors such as Constitutive 
Androgen Receptor (CAR) and the Pregnane X Receptor (PXR) to 
produce non-neuronal toxicities like obesity and fatty liver (Wahlang 
B, et al., 2016). However, as these nuclear receptors are also involved 
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in energy metabolism, they can also theoretically be responsible for 
neurotoxic effects of PCBs since neurones are highly energy-substrate 
dependent for their survival and functions. Likewise, ortho-PCBs can 
lead to alterations in cellular and mitochondrial enzymes like 
ethoxyresorufin-O-deethylase (EROD) and methoxyresorufin-O-
deethylase (MROD) by calcium buffering and increasing PKC 
translocation in neurones, an effect which various with different lots 
of Aroclor 1254 (S. Kodavanti, et al., 2001).  
Cross talks between caveolin 1 gene protein and Nrf 1, an 
erythroid like nuclear transcription factor can be responsible for 
endothelial injury caused by PCB 126 (Petriello MC, et al., 2014). 
Other cardiometabolic toxicities of this congener such as suppression 
of Phosphoenolpyruvate carboxykinase (PEPCK) are mediated 
through other nuclear receptors like AhR. Indeed, this is one of the 
principle enzymes regulating glucose metabolism in hepatocytes and 
other tissues (Zhang W, et al., 2012). The PCB 126 induced vascular 
inflammation and oxidative stress which increases the risk of cancer, 
atherosclerosis and neurocognitive deficits can be increased by dietary 
omega-6 fatty acids through such cross talks (Petriello MC, et al., 
2014).  
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3.2.3. Behavioural and cognitive toxicities of PCBs:  
Aroclor 1254 reduces the efficacy of spatial learning in avian 
models without affecting cue based selective preference to spatial or 
colour cues and memory retention (Zahara AR, et al., 2015). This 
statement undermines the toxicities of PCBs to migratory birds in 
relation to spatial learning on a paradigm equivalent to radial arm 
maze in European Starlings. Lactational and postnatal exposures of 
mice to Aroclor 1254 can also lead to anxiolytic effects on elevated 
plus maze and reduction in recognition memory on y-maze than is 
specific to female mice. These effects correlate more with NMDA 
receptor binding than dopamine assays in dentate gyrus and other 
areas in mouse brain (Tian YH, et al., 2011). It also increases 
acetylcholinesterase, corticosterone and total cholesterol levels in 
mouse brain, all of which are attenuated by treatment with the 
hematopoietic cytokine growth factor erythropoietin (Singh HJ, et al., 
2013).  
3.2.4. Inhalational toxicology of PCBs:  
Generally non-dioxin like, low chlorinated PCB congeners are 
more volatile and exposure to their vapour phase can lead to more 
probability of metabolic toxicities like diabetes mellitus (Aminov Z, et 
al., 2016). Examples of low chlorinated dioxin like PCBs include PCB 
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77 which are also more volatile but lead to more neuro-endocrine and 
carcinogenic effects due to greater ortho-substitution and dioxin like 
nature (Dziubanek G, et al., 2015), especially in winter. Semi volatile 
low chlorinated congeners like PCB 28 and PCB 52 can lead to 
carcinogenic effects by telomere shortening, cellular proliferation and 
effects on cell cycle (Senthilkumar PK, et al., 2011). The vapour phase 
low chlorinated PCBs like PCB 28 and PCB 101 can also produce 
deficits in attention level and span and increase emotional adverse 
effects in chronic indoor low dose exposures, but the cognitive, 
visuospatial and executive function toxicities are less well addressed 
(Peper M, et al., 2005). Higher chlorinated PCBs like PCB 126, PCB 
153, PCB 180 are more lipophilic in lieu of higher Kow; are 
metabolized to a lesser extent and are less volatile – they enter via 
other routes of exposure. After entry into the organism, they can cause 
cardiometabolic toxicities like changes in body weight, reduced 
plasma thyroxine levels, and higher lipid peroxidation (Hu X, et al., 
2015). The exposure to nose only chamber as opposed to whole body 
chamber generally produced higher target PCB concentrations in acute 
settings (Xin Hu, et al., 2015).  
In summary, the practical hazards of PCBs are significantly 
important in two scenarios –indoor risk assessment in occupational 
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exposures of workers to volatile PCBs, and horizontal transfer of 
PCBs from mother to child via placenta and lactational routes. In 
some countries, levels of inhaled PCBs are regulated – for instance in 
Switzerland, the allowed inhaled coplanar PCBs like PCB 77 is to be 
less than 6000 ng/cu.m leading to a TEQ (WHO Toxicological 
equivalents) of 0.6 pg TEQ / kg BW (Kohler M, et al., 2002).  
3.3 ESTIMATION OF PCBs BY CHROMATOGRAPHY: 
Estimation of various PCB congeners and mixtures are 
underrepresented in published literature. Most investigators have used 
Gas Chromatography (GC) methods although it is expensive and time-
consuming. Using Dichloromethane and hexane as the solvent, PCBs 
can be estimated in seal and crab tissues using high resolution (HR) 
GC/MS (Rather, et al., 2001 and 2003). For quantitation purposes, two 
such methods exist including aroclor specific and congener specific 
methods. For sample clean up in this study, gel permeation 
chromatography was utilized, and sample extraction was performed 
using fluorosil column. PCBs can also be estimated in environmental 
samples like air and water using liquid extraction (air) and solid phase 
extraction (water) by polyurethane foam resin based columns, and 
later quantified using GC methods coupled to Electron capture device 
(ECD) after radioisotope dilution (Muir et al., 2016). Stereoisomers of 
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PCBs can also be separated using chiral cyclodextrin based polymers. 
A maximum sensitivity of picograms / mol can be achieved with this 
method of quantification. Isomers of PCBs can also be quantified in 
rat liver microsomes using GC-ECD with yield of 1-100 ng/l (Zhai, et 
al., 2013). Using porous graphitic carbon based stationary phases, 
PCBs can also be estimated using quadrupole GC-MS methods with 
yield of up to 500 ppm / 20 mcl (Pietrogrande, et al., 2000). 
Metabolites of PCBs includes hydroxylated ones can be estimated in 
blood and plasma samples using tandem Electrospray Ionization (EI) – 
Mass Spectrometry (MS) assays, with KOH buffer, fluorosil column 
and nitrogen as the mobile phase (Letcher, et al., 2005). C18 gold 
HPLC columns can be used to estimate Aroclor 1260 in ground water 
samples, detected with UV-VIS spectrophotometry (Mathews, et al., 
2014). In this method, retention time of different PCBs were found to 
be within 14 minutes and the method is EPA-recommended for 
biomonitoring environmental samples (EPA, 2017).   
3.4. HISTOPATHOLOGY AND IMMUNOHISTOCHEMISTRY 
IN NEUROTOXICITY STUDIES: 
Microglial activation and dentate cell degeneration were 
observed in the olivocerebellar cortices of rodents treated with 
Ibogaine and cerebellum stained with Glial Fibrillary Acidic Protein 
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(GFAP), an astrocytic marker, and OF-3, a glial marker (Hearn et al., 
1997). In another study, toluene, an axonal toxin, caused dementia by 
causing cerebral and cerebellar atrophy with GFAP, Purkinje cell loss 
and white matter changes in cerebellum, and demyelination (Filley, et 
al., 2004). Androgens and anabolic steroids caused encephalopathy, 
visualized as axonal degeneration and microgliosis in cerebellum 
using silver stain (Namioshi, 2016). HIV-1 virion caused astrogliosis 
and related dementia in H&E stain in the hippocampus (Harricharan et 
al., 2015). Parkinsonian features in basal ganglia like glial cytoplasmic 
inclusions, neuroaxonal dystrophy with axonal spheroids, Lewy 
bodies, and oligodendroglial cells positive for alpha synucleins were 
noted in another study (Bellucci, et al., 2016). H&E staining also 
showed neuronal cell death after intrathecal vinca alkaloids, as shown 
by extensive Purkinje cell loss in cerebellum, perivascular and 
periventricular edema, axonal degeneration with interstitial edema, 
chromatolysis of neurones in basal ganglia, and intra cytoplasmic 
eosinophilic inclusions (Kwack, 1999). Chronic valproate therapy 
caused ischemia in cerebellum as exemplified by dark staining 
neurones, mitochondrial and golgi damage in Purkinje cells, swollen 
Bergmann’s astrocytes, and microtubular and neuronal changes in 
these cells using toluidine blue stain (Maria et al., 2001). Dark 
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neurones underlying ischemia in response to hypometabolism can also 
be viewed using H & E stain (Lomako, et al., 2015).  
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Figure 3: Study plan flow diagram 
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Materials & Methods 
5.1. Materials  
5.1.1. Aroclor 1232: chemical composition: 
Aroclor 1232 is a commercial mixture of polychlorinated biphenyls with 
32% chlorine by molar mass (Tables 1 & 2). Hence, this mixture is 
unique among most other Aroclors in that it has low chlorinated 
congeners (83% by mass). 
Table 1: Homolog composition of Commercial Aroclor 1232 
HOMOLOG 
DESIGNATION 
NATURE OF 
HOMOLOG 
COMPOSTION  
(mol %) 
Mono-CB 
Low Chlorine 
Congeners 
31 
Di-CB 24 
Tri-CB 28 
Tetra-CB 
High Chlorine Congers 
12 
Penta-CB 4 
Hexa-CB < 0.1 
Others (C12H10) Impurities < 0.1 
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Table 2: Congener composition of commercial Aroclor 1232 
MOST TOXIC 
CONGENER 
HOMOLOG 
FAMILY 
COMPOSITION 
(MOL %) 
PCB 105 Penta-CB 0.21 
PCB 118 Penta-CB 0.27 
PCB 138 Hexa-CB 0.06 
PCB 153 Hexa-CB 0.05 
PCB 163 Hexa-CB 0.01 
PCB 180 Hepta-CB 0.02 
 
The inhalational route was chosen as we aimed to assess the effects 
of this Aroclor, which contains high amounts of the semi volatile ortho- 
substituted PCBs (o-PCBs) by mass, as an occupational hazard risk in 
workplaces like indoor air vents, industrial releases, etc. For this purpose, 
as per the current OECD guidelines, we have selected a 6-hour dosing 
protocol on all 5 working days of the week for two weeks for the 
subacute toxicity testing. 
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5.1.2. Swiss albino mice: 
For each approval, a total of 66 swiss albino mice divided in a ratio 
of 2:1::female:male sex ratio was obtained and housed under standard 
conditions in the Animal Facility, after quarantine. At study initiation 
each time, all animals were aged 8-10 weeks age (adolescents) except the 
transgenerational phase wherein pregnant female mice were included 
(Figure 4). All animals were housed in four per cage (except pregnant 
females which were housed singly, with ‘n’ litters in the home cage), and 
weighed about 17-30 grams at initiation of each phase of experiments. 
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STUDY 
TIMELINE 
PHASE I: PARENT 
GENERATION 
PHASE II: F1 GENERATION 
BLOCK 
& AGE 
DETAILS BLOCK & 
AGE 
DETAILS 
BASELINE A1 
(12-14 
weeks) 
Quarantine, 
acclimatization 
& grouping; 
adult group 
exposure 
N.A. 
Stage I B1 
(15-17 
weeks) 
CNS 
assessments 
by checklist & 
instruments 
 
Stage II 18TH 
week 
Mating A2 
(GD 1-GD 
Care for pregnant 
females; treatment 
Stage III C1 
(19-20 
Recovery & 
isolation of 
20) of trans placental 
exposure group 
 weeks) females after 
confirming 
pregnancy 
B2 
(PND 1- 
PND 21) 
Monitor birth, care 
for litters, assess 
yield; treatment of 
lactational 
exposure group 
Stage IV D1 
(21st 
week) 
Observation of 
P generation; 
study 
termination of 
P generation 
C2 
(PNW 15- 
PNW 18) 
CNS assessment 
by checklist & 
instruments 
Stage V N.A.   
  D2 
(PNW 21- 
Adulthood) 
Observation & 
then, termination of 
F1 Generation use Stage VI 
Stage VII: BLOCK E (St udy termination) 
 
Figure 4: Study plan of the transgenerational study phase 
 
5.1.3. Chamber design: 
The whole-body inhalation chamber for exposure of rodents to 
toxic mixtures was developed with 5 different units – inlets, exposure-
housing unit, outlets / exhaust, chamber’s exterior environment, and the 
connecting tubing and valves (Figure 5). The exposure unit consisted of 
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sensors which recorded chamber environmental variables viz., relative 
humidity, pressure, temperature, flow rate and oxygen saturation every 
30 seconds. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Design of inhalational chamber used in this study 
 
 
5.2. Methods 
 The methodology consisted of following sequential steps: 
  a) Ethical approval 
  b) Chamber validation 
  c) Chamber optimization 
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  d) Acute toxicity tests 
  e) Sub acute toxicity tests 
  f) Transgenerational toxicity tests 
5.2.1. Ethical approval: 
 The study was conducted after ethical approval was obtained from 
the Institutional Animal Ethics Committee (PSG-IAEC). The IAEC is 
recognized by the National regulatory authority, viz., the CPCSEA for 
experimental research using small animals. After initial approval for the 
first year, later approvals were obtained on exempt basis for extension of 
the approval.  
5.2.2. Development and validation of inhalation chamber: 
We have followed a holistic approach in developing the whole-
body inhalation chamber for assessing the animal as a single unit, which 
usually is like workplace human exposure hazard. The flow in chamber 
was simulated to ensure uniform distribution of PCBs at the bottom of 
the inhalation chamber. 
We used a Whole-body rodent inhalational chamber (Figure 5) made of 
glass with two inlets and one outlet. The inlets were connected to a 
nebulizer and an air cylinder. The outlet carried the exhaust gas mixture 
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outside through a biohazard chamber out into the atmosphere through a 
chimney. All the five environmental parameters viz., relative humidity, 
pressure, temperature, flow rate and oxygen saturation inside the 
chamber for every 30 seconds. The chamber was validated for parameters 
like flow rate, relative humidity, pressure, temperature and oxygen 
saturation using atmospheric air without any animals. 
5.2.3. Chamber optimization - determination of vehicle (Methanol in 
water) concentration: 
A Latin square design for randomization of various dose parameters for 
optimization of vehicle to solvent ratio was used (Table 3). For the initial 
tests, a dose ranging from 0.1 to 1000 ppm of water aerosol in methanol 
was used in different combinations with dosing durations (1 sec, 3 min, 5 
min, 10 min, 30 min). Any acute signs of intoxication or mortality was 
noted later at each of these dose levels using 6 mice, with equal sex ratio. 
Behavior studies were performed to assess reproducibility of toxicity data 
on three occasions using acute 4-hour toxicity tests and behavioral and 
concentration assessments. 
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Table 3: Latin square design used for optimization of vehicle and solvent 
ratio. 
Chamber 
Optimization for 
Albino Mouse 
Dosing Concentration  
(Methanol in water in parts per thousand) 
1 3 10 30 100 400 2 
Dosing 
Duration 
1 
Male : Female 
1:1, N=50 
  
3   
10   
30   
100   
60      Female  
 15       Male 
 
During occupational dosing of Aroclor 1232, the chamber 
environment remained within acceptable limits for exposure of rodents as 
per standard guidelines like CPCSEA and OECD guidelines. The oxygen 
content in the chamber atmosphere was 21% without any change. The 
temperature in the chamber was between 20-28 C, and the chamber 
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pressure was 725-737 mm Hg. The relative humidity was nearly always 
between 20-80% and was conducive to the experimental animals. The 
flow rates varied between15-17 L/min inside the chamber during 
exposure, when the air flowed from the cylinder at 0.5 L/min, and the 
drug flow from nebulizer was 1.0 mL/min. All these conditions remained 
the same at all dose levels and durations in the optimization phase and 
the testing phase, both acutely and sub acutely. 
5.2.4. Acute toxicity tests: Selection of Aroclor doses: 
For the acute toxicity study (4 hours/day) a dose of 1.0 ppb of 
Aroclor 1232 in methanol was used arbitrarily, for the assessment of 
behavioral scores and their reproducibility on three days. Plasma 
concentrations of PCB 77 and PCB 180 were determined to confirm 
chamber flow simulation results. 
For the sub-acute occupational exposures, from a meticulous 
literature review, doses of 2, 4, and 16 mg/cu.m of Aroclor 1232 in water 
were chosen for different groups of mice, with the control group given 
water aerosol. For this study, all mice were exposed for 6 hours a day (9 
am to 3 pm) on all 5 working days of the week (except Saturday and 
Sunday) for two successive weeks. This study comprised of four different 
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sub study protocols – 48-hour intense pharmacokinetics study, 21-day 
toxicokinetics study, 2-week histopathology study and neurobehavioral 
study. 
 
Figure 6: Testing protocol for Aroclor 1232 dose deployment for   
assessment of its acute and sub-acute toxicity. 
 
5.2.5. Subacute toxicity tests: 
5.2.5.1. Bench mark dose   
The control dose for subacute testing was determined from the 
bench mark dose (BMD) and BMD Limit (BMDL) at 95% CI (Figure 7), 
4 mg/cu. m x 
6 hours/day 
x 5 days / 
week x 2 
weeks 
2 mg/cu. m x 
6 hours/day x 
5 days / week 
x 2 weeks 
16 mg/cu. m x 
6 hours/day x 
5 days / week 
x 2 weeks 
1 ppb x 4 
hours: acute 
testing for 3 
days 
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which gave further doses for the sub-acute studies – the BMD was 1000 
mcg/mL. 
 
Figure 7: BMD plot made using BMD Software of the US-EPA with Hill 
function, for the acute toxicity test with aroclor 1232. 
5.2.5.2. Irwin neurobehavioral assessment scale: 
As a blind screening tool, the Irwin neurobehavioral scale is a 
validated scale to be used to assess the cross sectional behavioral, 
autonomic, neurological, and physiological status of the laboratory 
mouse, both in normal and treated animals (Irwin, 1968). Additionally, it 
can be used to delineate the pharmacological effects of diverse groups of 
drugs acting on the nervous system.  
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It requires about three to eight minutes testing each mouse for its 
behavioral rating scores using this scale. The scale consists of about 
forty-seven different functions and processes, divided into eleven 
domains, each affecting the central, peripheral and somatic, and the 
autonomic nervous system, with effects related to cardiovascular and 
respiratory systems. 
Certain of these functions or sub domains can be tested by 
observation, whereas others can be assessed in the mouse after gentle 
maneuvers. Each sub domain has a minimum score, a normative score 
and a maximum score, ranging from 0-4. Hence, the total score that can 
be obtained by a normal control mouse, as described by the original Irwin 
procedure is 88. 
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Table 4: Irwin scale for behavioral assessment testing 
S. 
No. Domain Subdomain 
Normative 
score 
1 Awareness Alertness, Visual placing, Passivity, Stereotypy 
8 
2 Mood Grooming, Vocalization, Restlessness, Irritability / aggression, Fearfulness 
4 
3 Motor activity Reactivity to environment, Spontaneous activity, Touch response, Pain response 
16 
4 CNS Excitation 
Startle response, Straub tail response, 
Tremors, Twitches, Convulsions 
0 
5 Posture Body posture, Limb position 8 
6 Motor incoordination 
Staggering gait, Abnormal gait, Righting 
reflex 
0 
7 Muscle tone Limb tone, Grip strength, Body sag, Body tone, Abdominal tone 
16 
8 Reflexes Pinna, Corneal reflex, Ipsilateral Flexor Reflex (IFR) 
12 (8) 
9 Autonomic 
Writhing, Pupil size, Palpebral opening, 
Exophthalmos, Urination, Salivation, 
Piloerection, Hypothermia, Skin colour, 
Respiratory rate, Heart rate 
20 
10 Miscellaneous subdomains 
Exploratory activity, Hostility, Social / 
Group conglomeration 
4 
11 Lethality Acute, Delayed 0 
Total scores (normative) 88 
 
 
 
Chapter 5        Materials & Methods 
 
41 
 
The materials required for scoring include an arena, a linoleum 
mat, a platform with a mesh grid floor and a runway, a stainless-steel 
plate, a 21 G flexible hypodermic needle stylet, a 15 cm dissecting 
forceps, a lamp with torch light, and a wire-mesh grid. A checklist for 
scoring behavioral functioning, a pair of gloves, an inert dye, a 
randomization table, a measuring tape, and a calculator are also required 
as adjuncts. 
 
Figure 8: Standardization of the Irwin scale normative scores for acute 
testing with water aerosols. 
Before the initiation of Aroclor 1232 exposure, the mice were 
weighed and marked in segregated manner in groups of five per cage. 
Each animal was then randomized for hourly evaluation, according to 
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body weights using a table of random numbers, as shown in the 
following table: 
Table 5: Randomization schedule for animal selection 
Body 
Weight 
Range 
Randomization 
Rule (i=501) 
Identification 
mark 
Hour and day 
allotted 
17-24 g 
Every even 
numbered series 
(i+4, i+6,..) 
starting from the 
second random 
number (i+2) 
Head (H)-Blue 0 Hour, 
Day 1 
Continued 
till 2 
weeks of 
exposure 
Body (B)-Blue 2 Hour, 
Day 1 
Tail (T)-Blue 4 Hour, 
Day 1 
Head (H)-
Green 
6 Hour, 
Day 1 
Body (B)-
Green 
1 Hour, 
Day 2 
25-32 g 
Every odd 
numbered series 
(i+1, i+3,..) 
starting from the 
first random 
number (i) 
Tail (T)-Green 1 Hour, Day 1 
Head (H)-Blue 3 Hour, Day 1 
Body (B)-Blue 5 Hour, Day 1 
Tail (T)- Blue 0 Hour, Day 2 
Head (H)-
Black 
2 Hour, 
Day 2 
 
After randomization of animals for hourly behavioral assessment, 
the animal whose behavior has been randomly selected as representative 
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of baseline behavior is first observed and then manipulated for behavioral 
scores before treatment (hour 0, day 1). Ideally, this mouse score must be 
within acceptable limits of the normalized scores, which is 71±6 for 
animals treated with only water aerosol nebulization. 
 
  
Figure 9: Optimization of chamber conditions with water aerosol 
nebulization for sex differences in mice. 
Then, the inhalation treatment of all animals is undertaken with all 
ten mice inside the chamber per dose level. Apart from control group 
which was dosed with water aerosol, the neurobehavioral toxicities of 
Aroclor 1232 was tested with three other dose levels in geometric 
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progression – 2 mg/cu.m, 4 mg/cu.m, and 16 mg/cu.m. Each dose 
treatment was performed for two weeks on five days a week for six hours 
daily. Hourly behavioral assessment was conducted for the representative 
mouse as per the randomization schedule, during the inhalation exposure. 
The initial undisturbed observation consists of assessment of body 
position, locomotor activity, exophthalmos, respiration, tremors, 
twitches, convulsions, exploratory activity, hostility, and social 
conglomeration, as the mice remain inside the chamber. The animal is 
scored on a scale of 0-4 for each of these sub domain functions. After 
completion of this initial observation, the mouse is transferred from the 
chamber into the cage and then dropped onto the floor of the room for 
manipulated response grading for transfer arousal, spatial locomotion, 
palpebral closure, startle response, piloerection, tremor grading, gait and 
limb rotation. Following these scoring steps, the animal is lifted vertically 
by its mid tail above a wired mesh grid, and lowered slowly for 
assessment of visual placing response, i.e., extension of all limbs before 
contact. Grip strength and positional struggle behavior are then assessed. 
Body tone, gross signs of hypothermia, pinna and corneal reflexes, toe-
pinch response are then graded. After this, the mouse is transferred to the 
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chamber and graded for alley progression, withdrawal responses, touch-
escape response, and positional passivity. Finally, autonomic signs like 
diarrhoea, skin / fur colour, limb tone, abdominal tone, pupillary reflex, 
lacrimation, salivation, pupillary size, and provoked biting response (for 
aggression) are observed followed by tail-pinch response, righting reflex, 
provoked freezing, grasp irritability, vocalization and defecation and 
urination assessments.  
Each hour following the day 1 hour 0, such assessments are done 
for one representative animal and the individual sub domain scores are 
totaled to obtain the hourly scores of behavioral assessments.  Statistical 
analysis was performed using non-parametric tests like two-way Analysis 
of Variance (ANOVA) with Bonferroni test and Mann-Whitney U test to 
compare the behavioral scores across each of hour-wise and day-wise 
comparisons with each dose level.  
5.2.5.3. Cognitive and neurological testing: 
Neurological and cognitive paradigms included y-maze, elevated 
plus maze and open field tests performed at baseline (week 0), Midphase 
(week 1) and termination of two-week treatment for each dose level 
(week 2).  
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Y maze is a tri-arm elevated asymmetrical maze consisting of two 
equally long arms, and a longer arm, each forming a total equilateral ‘Y’ 
that can be used to assess spatial short-term memory (alternation test) and 
working associative memory (novelty preference test). It is also used for 
training of mice to a pre-defined cognitive criterion before administration 
of Aroclor 1232. This habituation phase consists of two phases conducted 
before week 0 assessments. First the mice are freely allowed to explore 
all three arms of the y maze for 8 minutes to achieve familiarization of all 
arms as a part of natural tendency of rodents to explore places. Twenty-
four hours later, the mouse is placed on the start arm of the maze and 
allowed to familiarize the other / familiar arm in preference to start arm, 
with the novel arm closed, during the 8-minute training trial. The 
animal’s familiarization index must exceed 1.0 in more than 2 out of 4 
such trials within 24 hours duration – otherwise it is rehabilitated and 
replaced by a new animal.  
𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝐹𝐹𝐹𝐹𝑖𝑖𝑖𝑖𝑖𝑖 = ∑𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝐹𝐹𝐹𝐹𝐹𝐹
∑𝑆𝑆𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝐹𝐹𝐹𝐹𝐹𝐹  
Twenty-four hours after the last of such trials, the baseline week 0 
assessment is done using y maze novelty test and alternation test and 
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elevated plus maze anxiety test and open field test. After another day, the 
treatment with Aroclor 1232 aerosol is initiated for two weeks using 
occupational protocol, with a provision for mid-phase and terminal phase 
assessments and hourly behavioral evaluations. 
The acquisition (1 week) and retention trials (2 week) on the y 
maze are conducted on days 7 and 14 respectively. An alternation is 
defined as the consecutive entry of the mouse into three different arms 
successively either clockwise or anticlockwise. The number of such 
alternations is noted in a 8 minute trial, and the alternation index as a 
measure of spatial associative memory is calculated as follows: 
Alternation Index = ∑𝐴𝐴𝐹𝐹𝐹𝐹𝑖𝑖𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐴𝐴 ∑𝐴𝐴𝐹𝐹𝐹𝐹 𝑖𝑖𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝑖𝑖𝐴𝐴 − 2�  
The elevated plus maze has two opposite open arms and two 
opposite enclosed arms all four at 90 to each other at the central joining 
platform. During a single acquisition trial every week, the mouse is 
placed on one of the open arm ends with face outwards, and the time it 
takes to move it three-fourths of body into one of the enclosed arm 
(transfer latency) in a 90 second trial is noted. This is a measure of 
anxiolytic or anxiogenic activity of PCBs. 
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Figure 10: Elevated plus maze for mice. 
Open field box is used to assess the effects of PCBs on the 
spontaneous motor activities of mouse in a three-minute trial. The square 
shaped box consists of a blue painted floor with 4x4 small squares 
(yellow border) and a central red square. The rodent innately prefers 
peripheral squares and corners in relation to the central red square; the 
spontaneous motor activity index defined as a ratio of number of yellow 
square to red square entries is a measure of the effects on anxiety – 
greater the ratio, higher the anxiogenic effect and greater the red square 
entries, higher is the anxiolytic effect. This ratio is measured weekly 
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once, with the animal placed in the red square and both numerator and 
denominator are counted in three-minute trials. 
 
Figure 11: Open field box for mice. 
The Novelty object recognition (NOR Index) is calculated as a measure 
of spatial short-term memory in a 5-minute weekly trials, as follows: 
𝑁𝑁𝑁𝑁𝑁𝑁 𝐼𝐼𝐹𝐹𝑖𝑖𝑖𝑖𝑖𝑖 =  ∑𝑁𝑁𝐹𝐹𝑁𝑁𝑖𝑖𝐹𝐹 𝐹𝐹𝐹𝐹𝐹𝐹 𝑖𝑖𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝑖𝑖𝐴𝐴
∑  (𝑓𝑓𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 +  𝐹𝐹𝐹𝐹𝑁𝑁𝑖𝑖𝐹𝐹 𝐹𝐹𝐹𝐹𝐹𝐹 𝑖𝑖𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝑖𝑖𝐴𝐴) 
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Figure 12: Y maze Novelty test. 
5.2.6. One-generation behavioral toxicity assessment: 
  Two groups with eight mice per group were randomized into 
different cages based on body weight and all sixteen mice were females 
aged 10-12 weeks at initiation of experimental procedures. These sixteen 
mice comprised of two groups of parent generation (P) –Groups I and II, 
the former being unexposed control group and the latter being exposed 
for two weeks on an occupational exposure protocol to 4 mg/cu.m 
(intermediate dose level) of Aroclor 1232 via inhalational route (Figure 
13). The control group mice were nebulized with water aerosols. 
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Figure 13: Diagram depicting the components of occupational exposure 
protocol in the test group (transgenerational behavioral toxicity). 
During daily exposures in both groups, pre-exposure and hourly Irwin 
behavioral scores were assessed from a randomly selected representative 
mouse for each time-point, using a randomization schedule. At 14 weeks 
of age, after assessment of parent generation anthropometric parameters 
(male and female tail and trunk lengths, body length, trunk: tail ratio, 
body weight), all animals in the treated group could mate with a fixed 
number of male mice (two males for eight females), using harem mating. 
The males could mate with females (only in the treated groups) for seven 
days, in a single home cage, without separation of male and female mice. 
4 mg/cu.m 
(inhalational)
6 hours 
per day
5 days 
per 
week
2 weeks 
totally
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After confirmation of pregnancy by yellow plug / discharge observation 
and gentle abdominal palpation on days eight-ten, male mice were 
separated, and females could live in separate cages to prevent 
cannibalism, with four per cage. During this four-day period, the home 
cages housing female mice were cleaned twice daily to prevent infections 
due to coprophagy. After confirmation of pregnancy in at least 50% of 
female mice no later than day eleven from the time of mating (day 1 at 
14-15 weeks of age), two female pregnant mice between 30-45 grams of 
body weight which conceived the last of all mice in the four-day window 
period were selected for evaluation of one-generational behavioral 
toxicity. This day of confirmation of pregnancy was taken as one-day 
pre-Gestational Day 0 (GD 0) for practical purposes in the mouse to be 
used for trans-placental toxicity assessment. This animal was nebulized 
in the chamber with Aroclor 1232 from the next day for two weeks (GD 
0- GD 13), based on occupational exposure protocol. Hourly behavioral 
assessments and weekly body weight were performed. After GD 13, the 
animal was observed in the home cage daily till delivery, which was GD 
18. The delivery could take place under supervision in the animal facility, 
and the health and diet of both parent mouse and litters was strictly 
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controlled and enriched. The number of litters and male: female sex ratio 
of litters was recorded on Post Natal Day (PND) 7. Any dead or 
abnormal litters which did not survive till PND 7 were also recorded for 
gross pathology, and disposed by standard ethical and regulatory 
procedures including burial and or incineration of specified related 
biomedical wastes. The other unexposed pregnant female mouse was 
delivered and cared for as per the same procedure till PND 7, with litters 
separated from parent mice till PND 7. On PND 8, this second mouse 
could initiate lactation in home cage, and then within one hour, this 
parent mouse was started with Aroclor 1232 nebulization, with hourly 
behavioral assessments. The exposure was performed with the same 
protocol till PND 21 in this second mice, with lactation interrupted 
during exposure of parent mouse. Anthropometric assessment was done 
in litters of both parents on PND 28. These litters were observed till age 
of 14 weeks, after which three litters per group (now aged 14 weeks) 
were sacrificed for estimation of PCBs in brain and plasma. 
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5.2.7. Outcome assessment methods: 
5.2.7.1. Method development and estimation of PCBs in mouse 
samples by UPLC-DAD: 
The estimation of PCB 77 and PCB 180 as representative analytes 
and of PCB 101 as the internal standard was done using Ultra-High-
Performance Liquid Chromatography (UPLC) coupled to Diode Array 
Detector (DAD) in both plasma and brain matrices of exposed mouse. 
The Stationary phase was a reverse phase C18 column and the mobile 
phase of 90% methanol in water was used for this purpose.  The solvent 
for reconstitution of the extracted sample was 90% acetonitrile and the 
extraction solvent were Tert-butyl methyl ether (TBME). All samples 
were cleaned up using rotary shaker followed by nitrogen evaporation 
which yielded the extracted samples at 45-50 C for 30 minutes. 
After the clean-up, extraction and processing of samples, the calibration 
curve was plotted with a series of dilutions of all three standards, which 
yielded the linearity range.  
5.2.7.2. Euthanasia and sample processing and storage: 
After two weeks of exposure the animal was euthanized by ether 
overdose, and by a meticulous assessment of signs of euthanasia. Just 
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before complete euthanasia of animal has taken place, the animal’s tail 
region was venepunctured for drawing terminal volume (0.3 mL on 
average) was withdrawn in 0.012 mM Calcium disodium EDTA tubes at 
p H of 8.0 (60 mcL in microcentrifuge tubes for drawing a total of 300 
mcL of blood). This blood sample was centrifuged at 3400 rpm for 10 
mins. At 4°C to draw plasma from the rest of blood components in a 
separate coded tube. This plasma sample was stored in deep refrigerator 
(-70°C) after due inspection and coding. During the centrifuge of the 
blood, the head was incised and decapitated for sampling whole brain in 
0.1 mL of ice cold (4°C) 1 M PBS solution, which was also coded and 
stored in 15 mL Tarson tubes at -70°C till further analysis. 
5.2.7.3. PCB Estimation: 
PCB 77 and PCB 180 were estimated in plasma and brain samples 
of treated mice using Water Acquity (Waters, USA) UPLC-DAD system. 
Liquid-liquid extraction technique was used with acetonitrile for 
extraction of samples. The mobile phase was methanol which was 
programmed for isocratic elution of PCBs at a constant flow rate of 0.3 
mL / min. Reverse phase C18 column (Acquity BEH shield) was the 
stationary phase for elution of analytes and the internal standard, PCB 
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101, at a column temperature of 35°C. PCB 77, IS, PCB 180 eluted at 
2.6, 2.8 and 4.7 minutes retention times, with the total run time of 6 mins. 
The linearity range was 10-3000 ng/mL for both the analytes. This 
method was precise and accurate with good yield of analytes and was 
applied for all pharmacokinetic and toxicokinetic studies for estimation 
of PCBs in brain and plasma.  
5.2.7.4. Histopathological and immunohistochemical examination: 
Apart from the basic Haematoxylin-Eosin stain that identifies 
neurones, a series of immunohistochemical markers were examined, 
including anti-apoptotic bcl 2 and bcl 6, Oestrogen receptor (ER-), 
astrocyte Glial Fibrillary Acidic Protein (GFAP), marker for neuronal 
metabolism – Neuronal Specific enolase (NSE), TdT – Terminal Deoxy 
Thymidine which is a pro-apoptotic marker and a confirmatory marker 
for neurons viz., Neuronal Nuclear Antigen (Neu-N).  
All sample preparations and sections were performed in a NABL 
accredited laboratory, for each dose level. A single mouse aged 8-12 
weeks of age was acclimatized for laboratory conditions for three days 
and then exposed to two weeks of Aroclor 1232 by occupational and 
inhalational exposure protocols for each dose level.  
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The brain was fixed in a 400 mL of 6 % formalin solution for 20-30 days 
and then sectioned in cassettes for further staining and analysis (Figure 
14). 
 
Figure 14: Steps followed for HPE/IHC staining protocols 
5.2.7.5. Monoamine estimation: 
For monoamine estimation, analytical standards including 
Dopamine hydrochloride, L-Noradrenaline hydrochloride and Serotonin 
hydrochloride and the metabolites viz., 5-hydroxyindole acetic acid and 
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DOPAC were purchased from Sigma (Sigma-Aldrich, India) and stored 
at 4°C till use. All standards in powdered or granule formulation were 
appropriately weighed and solubilized in water after which the solution 
was sonicated and acetonitrile was added to make 8 mL of each of the 
standard solutions. The mobile phase for HPLC was 5% methanol in 
water which was buffered using a monoamine buffer mix containing 70 
mM potassium dihydrogen phosphate, 0.1 mM dipotassium EDTA salt, 
1.1 mM heptane sulfonic acid and 0.4 % Trifluroacatic acid added to 
1000 mL water, and adjusted to a pH of 3.14 using saturated (~100%) 
citric acid solution. At pH adjusting phase, a magnetic stirrer was used 
for mixing the buffered mobile phase, which was then filtered to prevent 
sedimentation and microbial growth. The IS for monoamine estimation 
was 100% paracetamol in ACN which was sonicated to prevent 
precipitation and ensure miscibility. A calibration curve was then plotted 
for all 5 standards after injection of each standard into HPLC and 
detected using FLD detector, for calculation of linearity range.  
For sample analysis, the coded brain samples were thawed to room 
temperature for nearly 30 minutes, followed by gentle 10 second 
vortexing. Then, 200 mcL was transferred to 2 mL tubes, which was 
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centrifuged at 10,000 rpm and 4°C for 5 minutes for separation into a 
supernatant and a pellet. 150 mcL of the supernatant layer was then 
transferred into another 2 mL tube without disturbing the translucent 
layer below, which was covered with aluminium sheet and refrigerated 
till analysis by injection of 1 mcL sample into HPLC. Blank brain 
samples were used for control purposes, which were obtained from mice 
treated with water-only aerosols.  
5.3. Statistical analyses: 
All the study variables like concentration of PCBs, monoamines, 
behavioral scores and neurocognitive endpoints were treated as 
continuous ones. Additionally, behavioral sub scores were transformed 
into categorical variables for comparisons across time (hours and days of 
exposures) which are also continuous variables, and across dose levels. 
Finally, doses were treated as logarithmically or non-transformed graded 
variables for dose response analysis. All statistical tabulation and analysis 
including dose response, concentration time and concentration-time-
dose-response analysis were performed using Graph-Pad Prism v 5.0, R 
statistical package, MS Excel 2013, and BMDS of the US-EPA. t-tests, 
two-way ANOVA, regression-correlation analyses were performed to 
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obtain statistical significance level at an alpha error of 5 % or less. OECD 
guidelines for toxicity testing allow 8-10 rodents per dose level which 
was complied with for optimum power calculations, accounting for 
minimum beta error. Most distributions were assumed to be statistically 
non-parametric in nature; hence such tests were preferred for post hoc 
analysis after homogeneity testing and ANOVA. WIN-O-LIN was used 
for non-linear pharmacokinetic modelling of PCBs. 
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CHAPTER 6: Results & Analysis 
6.1. Effects of Aroclor 1232 on Behavior 
6.1.1. Normative scores for sub-acute toxicity tests: 
Based on the acute and sub-acute testing using water as 
aerosols, the normative behavior scores for sub-acute toxicity testing 
was defined to be 71 ± 6. 
6.1.2. Behavioral scores showed opposingCentral Nervous 
systemeffects: 
A two-way ANOVA for testing degrees of significance in the 
interactions between doses, hours and days of exposure revealed 
significant interaction between dose x hours versus days of exposures 
(p < 0.0001 versus 0.14) (Figure15). 
A post-hoc Bonferroni test for pairwise comparisons of scores 
across doses yielded statistical significance between control and 16 
mg/cu.m dose scores at days 6 and 7 (p < 0.05), between 2 mg /cu., 
and 4 mg/cu.m scores on day 6, and between 4 and 16 mg/cu.m doses 
on days 6 and 7 (p < 0.001). 
Hence, 2 mg/cu.m dose produced statistically non-significant 
change in scores compared to control group at all timepoints of 
exposure, compared to control groupscores.The 4 mg/cu.m dose 
produced behavioral depression on day 6, as shown by a statistically 
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significant dip in scores at this timepoint, compared with the control 
mice. 
The 16 mg/cu.m dose level caused the behavior of mouse to 
excite on days 6 and 7 of exposure, which is denoted by a significant 
peak in scores, compared to controlgroup. 
6.1.3. Behavioral scores were time dependent across hours than days 
of exposure: 
The total scores for behavioral assessment were both time and 
dose dependent and showed trend across doses, and, hours of 
exposure much greater than over days of exposures. 
There was a significant difference in total scores at 3, and 4 
hours for all doses, and at 5 hours of daily exposure for 2 and 4 
mg/cu.m doses(p< 0.05), when compared to control group, across all 
days (Figure 16). 
6.1.4. Overall effect of Aroclor 1232 on behavioral domains: 
The sub scores that contributed to greater than 50% deviation 
from the normative values, as assessed by Mann Whitney U test were 
distributed across three main domains – mood, autonomic activity 
and miscellaneous functions, for all dose levels. 
6.1.5. Effects of Aroclor 1232 on behavioral sub-domain scores 
A more detailed analysis of subdomain score across doses 
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revealed that grooming and restlessness (mood), urination, heart and 
respiratory rates, skin Colour and palpebral opening (autonomic), and 
exploratory and group clustering behaviors (miscellaneous domain) 
were contributing to the statistical significance in the behavioral 
changes compared to control group. 
6.1.5.1. Mood was depressed due to altered grooming and 
restlessness sub scores compared to control group at same 
timepoints: 
Generally, a decline in mood was noted due to dipping of 
scores for grooming and restlessness subdomains. The mean 
grooming scores across all days dipped at 5 hours for higher dose 
levels as compared to 4 and 6 hours for 2 mg/cu.m dose. The trough 
in mean restlessness scores across all days was 3 hours for low dose 
and this shifted by one hour for each geometric increase in dose.  
6.1.5.2. Five out of eleven sub domains were altered between test 
groupsand control group timepoints in the autonomic function 
domain: 
In this study, the mean palpebral opening was below the 
normative value at all timepoints, with the maximum dip approached 
at 4 hours for 2 mg/cu.m dose and at 5 hours for higher doses. 
Although the heart rate was below the normative score during all time 
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points, there was a tendency for maximum bradycardia at 3-5 hours 
across all dose levels.  
Similarly, the respiratory rate tended to be below the normative 
always and to initially dip at about 2-3 hours and then recover to 
baseline value at 5 hours across all days and dose levels. Urination 
scores increased at 5 hours for 2 and 4 mg/cu.m doses across the day 
averages, whereas it reduced at 4 and 5 hours for the 16 mg/cu.m 
dose.  
6.1.5.3. Miscellaneous subdomains also contributed to 
differencesinbehavior including exploratory activity and Group 
clustering: 
Among the miscellaneous domains, group clustering activity 
increased with duration of exposure each day as the animals tended to 
reduce the surface area of their fur to avoid exposure to the 
potentially irritating PCBs. This was inversely proportional to the 
exploratory activity of mice in the chamber. 
6.2. PCB 77 and PCB 180 concentrations compared with 
Behavioral scores: The Pharmacokinetics study–PCB 77 is 
responsible for the behavior disruption caused by Aroclor 1232 
inhalation in mice: 
The reduction of scores of most domains and subdomains was 
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due to depressant effects of PCB 77 as noted by a maximum Cmax of 
this analyte being reached in plasma (and brain) when the scores 
decreased (at 4-5 hours). However, the plasma and brain PCB 180 
did not correlate with behavioral disruption. 
6.3. Neurological paradigms– 
6.3.1. Novelty recognition spatial associative recognition memory 
reduced with dose and with time in each dose level: 
Novelty recognition generally reduced with exposure and 
reached maximum trough at the end of 2 weeks of exposure. It 
showed significant difference compared to control means especially 
at 4 and 16 mg/cu.m doses, and the time of exposure showed 
statistically significant interaction with the indices rather than the 
doses (Figure 15). 
6.3.2. Y-maze alternation index andspatial working memory 
wasnotsignificantly different in all dose levels: 
The alternation indices increased after Midphase at 2 mg/cu.m 
dose and reduced in higher doses. The alternation indices were 
statistically not significant in being different from terminal scores of 
the control group, as revealed by ANOVA. 
6.3.3. Anxiety levels showed opposing trends across both dose levels 
and time points: 
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This latency followed the same trend as the alternation, 
increasing after Midphase in low dose and reducing in higher doses. 
The reduction in anxiety in high dose could have been due to 
masking by increased sedative effects in these dose levels (Figure 
15). Although the differences in mean latencies was not significantly 
different from control values, the dose interaction with the latencies 
was significant. 
6.3.4. Increased locomotor stimulation was apparent across dose 
levels with time: 
In this study, the open field activity increased as exposure 
progressed except in 16 mg/cu.m dose where it reduced, probably due 
to depressant effects of PCBs in high dose (Figure 15). All the mean 
locomotor differences were however statistically not significantly 
different from control values. 
6.4. Toxicokinetic concentrations of PCBs versus neurological 
parameters 
6.4.1. PCB 77 has greater effect in disrupting higher brain 
functions: 
The cognitive and sensory-motor paradigm parameters 
correlated directly with PCB 180 concentrations in brain and were 
inversely proportional to PCB 77 brain and plasma concentrations, 
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making PCB 77 responsible for the changes produced in these 
paradigms during the toxicokinetic timepoints.  
6.5. Histopathology– 
6.5.1. Anti-apoptotic pathways get activated to compensate Aroclor 
1232 toxicity 
Histopathology staining of neurons with H & E showed focal 
increase in darkly staining neurons in high dose levels. 
The immunohistochemical markers revealed darkly staining 
eosinophilic proapoptotic cells in brains of animals exposed to higher 
doses of PCBs. Interestingly, anti-apoptotic bcl2 and bcl6 was 
overexpressed in neurons of mice exposed to PCBs compared to 
control animals, suggesting a compensatory mechanism to offset the 
toxic effects of PCBs in higher doses. The markers reveal weak 
positivity of bcl 6 cells in 4 mg/cu.m dose level in the cerebral cortex 
of mouse. Bcl 6 was positive in intermediate and high doses in the 
cerebral cortex of the mouse brain. Estrogen receptor alpha was 
positive in the hippocampus of 16 mg /cu.m dose, and 
intracytoplasmic in cerebral cortex. 
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6.6. Effects of inter-generational transfer of PCBs onbehavior: 
6.6.1. PCBs transfer across translactational route greater 
thanplacentalroute: 
A two-way ANOVA across all individual pairs of data in all 
the four groups – control and exposed parents, transplacental and 
translactational groups in offspring mice was performed to determine 
the probable route of PCB transfer across one generation. 
The translactational group behavioral scores were significantly 
different on most of the ten days of exposure compared to all the 
three other groups, pair wise comparison yielding p values from < 
0.001 to < 0.05 on most days. However, none of the other pairwise 
comparisonsresulted in statistical significance across any days of 
exposure. 
Also, the group x hours of exposure variances contributed 
significantly to the difference in scores across days of exposure as 
indicated by post hoc comparisons (p < 0.05). 
The mean scores were significantly lower in translactational group 
compared to all the other groups at all 10 days except day 5 and 8 of 
exposure; however, no such significant difference existed between 
parents and transplacental transfer group mice in the behavior scores 
(p < 0.05). 
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6.6.2. Concentrations of PCBs across one generation: 
6.6.2.1. All offspring mice brain PCB concentrations were below 
LLOQ: 
Although the parent mice brains showed the presence of PCB 
77 and PCB180 in low concentrations, the concentrations of both 
compounds were below the LLOQ in the offspring mice at 14 weeks 
of age – probably due to low analytical detectability and due to less 
cumulation due to shorter duration of exposure of 2 weeks, as 
showed by the lower peak brain concentration (Cp) at 48 hours in the 
parent generation mice.  
6.7. Brain monoamine levels: 
All parent monoamines – Noradrenaline, serotonin and 
dopamine were detected in all brain samples including control mouse 
samples, along with the metabolites 5-HIAA and DOPAC. The 
pharmacokinetic study samples showed a trend for reduced serotonin 
and dopamine whereas toxicokinetic study samples showed increasing 
levels of the monoamine parent compounds as dose and time 
increased. All the levels correspond to alterations of behaviour 
(pharmacokinetics study) and neuro-cognitive endpoints 
(toxicokinetics study). The metabolites showed a trend direction that 
was opposite or inversely related to parent concentrations.  
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6.8. Pharmacokinetic parameters of PCB 77 and PCB 180:  
The pharmacokinetic variables calculated using WIN-O-LIN for 
both PCB congeners in both matrices is summarized from Tables 7-
19. The key parameters include Cmax, AUC0-t, AUC0-∞, Tmax, and t1/2 in 
plasma and brain samples which were calculated using 
pharmacokinetic samples.  
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Figure 15: Graph of mean hourly scores across all 10 days across the 
three doses (dashed line shows the median scores of control animals, 
with SD denoted on either side by straight line). 
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Figure 16: Mean behaviour scores all 10 exposure days at 1-6 hours 
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Table 6: Statistical hypothesis testing results across various time 
points for 
Neurological paradigms. (N.S = Not Significant) 
Paradigms Groups Week 0 
Week 
1 
Week 
2 
ANOVA – p values Significant 
Interaction 
(p < 0.05) 
Week 
0 vs. 
1 
Week 
1 vs. 
2 
Week 
0 vs. 
2 
 
NOR INDEX (%) 
CONTROL 60.72 56.29 47.30 N.S. N.S. N.S.   
 
Week 
2 mg/cu.m 61.95 38.91 33.84 N.S. N.S. 
P < 
0.05 
4 mg/cu.m 64.66 57.79 36.88 N.S. N.S. 
P < 
0.05 
16 
mg/cu.m 54.36 41.30 35.05 N.S. N.S. N.S. 
 
ALTERNATION 
INDEX (%) 
CONTROL 31.83 17.42 25.28 N.S. N.S. N.S.  
 
 
N.S. 
2 mg/cu.m 28.01 26.20 50.83 N.S. N.S. N.S. 
4 mg/cu.m 18.46 18.37 12.28 N.S. N.S. N.S. 
16 
mg/cu.m 26.75 23.82 20.30 N.S. N.S. N.S. 
 
TRANSFER 
LATENCY (sec) 
CONTROL 31.33 23.00 22.50 N.S. N.S. N.S.  
 
 
Dose 
2 mg/cu.m 51.33 73.67 79.17 N.S. N.S. N.S. 
4 mg/cu.m 23.67 34.83 14.83 N.S. N.S. N.S. 
16 
mg/cu.m 57.30 62.30 29.00 N.S. N.S. N.S. 
 
OPEN FIELD 
TEST (ratio) 
CONTROL 21.95 22.57 25.61 N.S. N.S. N.S.  
 
 
N.S. 
2 mg/cu.m 25.28 47.29 23.10 N.S. N.S. N.S. 
4 mg/cu.m 35.19 39.36 22.28 N.S. N.S. N.S. 
16 
mg/cu.m 26.90 39.50 37.70 N.S. N.S. N.S. 
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Figure 17: Day wise cross-sectionalmood trendlines for third hour of 
exposure (The gray line is the normative sub score). 
 
Figure 18: Day wise cross sectionalmood trendlines for forth hour of 
exposure (The gray line is the normative sub score). 
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Figure 19:   Day wise cross sectional mood trendlines for fifth hour of 
exposure (The gray line is the normative sub score). 
 
Figure 20: Day wise cross sectional autonomic trendlines for third 
hour of exposure (The gray line is the normative sub score). 
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Figure 21: Day wise cross sectional autonomic trendlines for forth 
hour of exposure (The gray line is the normative sub score). 
 
Figure 22: Day wise cross sectional autonomic trendlines for fifth 
hour of exposure (The gray line is the normative sub score). 
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Figure 23: Y maze alternation index trendlines with toxicokinetics 
study timelines in high dose group. 
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Figure 24: Trend of NOR indices with concentration profiles of PCBs 
77 & 180. 
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Figure 25A: 2-way ANOVA showing dose-response relationship 
across days of exposure (RM = Repeated Measures) 
 
 
Figure 25B: Bar chart depicting day wise scores across three groups of 
the transgenerational toxicity study phase 
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A
B
C 
Figure 26: H & E histopathological staining of Cerebrum, 
Hippocampus & Cerebellum in control mouse (A,B,C panels) 
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A 
B 
C 
Figure 27: Confirmation of neurones (Cerebral cortex, A) by Neu-N, 
astrocytes (Hippocampus, B) by GFAP and neuronal metabolism 
(Cerebellum, C) by NSE IHC in control mouse. 
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Figure  28: Focal dark / eosinophilic neurones in cerebrum of 16 
mg/cu.m mouse in H&E HPE. 
 
Figure  29: Bcl 6 positivity in hippocampus of mouse treated with 
high dose Aroclor 1232 
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A 
B 
 
Figure  30: ER alpha cytoplasmic positivity in cerebrum of high dose 
treated mouse (A panel) with neuroglial positivity in the hippocampus 
(B panel). 
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A      B 
 
C      D 
 
Figure 31: Bcl-2 positivity in a progressively increasing fashion with 
increasing dose starting from control (A), low dose (B), intermediate 
dose (C) and high dose (D) of cerebellar cortices of mice. 
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Table 7 – Pharmacokinetic parameters of PCB 77 and PCB 180 in low dose group (2 mg/m3) 
 
Parameter Units 
PCB 77 PCB 180 
Mean ± SD 
 (N = 6) 
Mean ± SD 
(N = 6) 
Plasma Brain  Plasma  Brain  
Cmax ng/ml 88.32 ± 8.28 
69.43 ± 
10.54 
66.49 ± 
5.22 
42.04 ± 
4.83 
Tmax hr 3.50 ± 1.00 
3.50 ± 
1.00 
2.00 ± 
0.00 
2.00 ± 
0.00 
AUC0-t ng.hr/ml 1321.19 ± 55.72 
1254.97 ± 
57.51 
763.27 ± 
38.80 
631.12 ± 
46.60 
AUC0-∞ ng.hr/ml 1626.02 ± 64.13 
1469.62 ± 
161.80 
1226.52 ± 
136.72 
915.48 ± 
106.63 
HLλz t1/2 (hr) 20.17 ± 1.38 
16.20 ± 
4.36 
28.95 ± 
3.39 
22.17 ± 
3.24 
MRTlast hr 16.51 ± 0.42 
17.07 ± 
1.93 
13.11 ± 
0.96 
13.88 ± 
0.21 
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Table 8 – Pharmacokinetic parameters of PCB 77 and PCB 180 in intermediate dose group (4 mg/m3) 
 
Parameter Units 
PCB 77 PCB 180 
Mean ± SD 
 (N = 6) 
Mean ± SD 
(N = 6) 
Plasma Brain  Plasma  Brain  
Cmax ng/ml 245.62 ± 39.58 
175.13 ± 
6.42 
370.21 ± 
42.59 
135.49 ± 
4.95 
Tmax hr 4.00 ± 0.00 
4.00 ± 
0.00 
2.00 ± 
0.00 
2.00 ± 
0.00 
AUC0-t ng.hr/ml 2749.52 ± 392.00 
2366.40 ± 
142.19 
4369.75 ± 
730.55 
2449.37 ± 
186.79 
AUC0-∞ ng.hr/ml 2957.28 ± 413.20 
2581.12 ± 
136.46 
5425.39 ± 
408.95 
3896.91 ± 
367.99 
HLλz t1/2 (hr) 12.72 ± 0.36 
14.20 ± 
0.58 
20.04 ± 
6.43 
31.43 ± 
3.10 
MRTlast hr 14.31 ± 0.49 
15.05 ± 
0.32 
15.43 ± 
0.85 
19.45 ± 
0.64 
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Table 10 – Pharmacokinetic parameters of PCB 77 and PCB 180 in high dose group (16 mg/m3) 
 
Parameter Units 
PCB 77 PCB 180 
Mean ± SD 
 (N = 6) 
Mean ± SD 
(N = 6) 
Plasma Brain  Plasma  Brain  
Cmax ng/ml 727.40 ± 42.52 
66.49 ± 
5.22 
829.57 ± 
31.40 
429.35 ± 
14.37 
Tmax hr 4.00 ± 0.00 
2.00 ± 
0.00 
6.00 ± 
0.00 
6.00 ± 
0.00 
AUC0-t ng.hr/ml 7565.21 ± 148.44 
763.27 ± 
38.80 
13192.39 ± 
498.68 
8332.99 ± 
123.54 
AUC0-∞ ng.hr/ml 8013.39 ± 263.11 
1226.52 ± 
136.72 
15636.03 ± 
1053.10 
10984.01 ± 
590.37 
HLλz t1/2 (hr) 11.17 ± 1.54 
28.95 ± 
3.39 
18.21 ± 
1.94 
22.73 ± 
3.57 
MRTlast hr 14.29 ± 0.24 
13.11 ± 
0.96 
16.24 ± 
0.32 
18.72 ± 
0.21 
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Figure 32: Brain serotonin c x t graph for low dose group 
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Figure 33: Brain serotonin c x t graph for middle dose group 
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Figure 34: Brain serotonin c x t graph for high dose group 
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Figure 35: Brain 5-HIAA c x t graph for low dose group 
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Figure 36: Brain 5-HIAA c x t graph for middle dose group 
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Figure 37: Brain 5-HIAA c x t graph for low dose group 
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Figure 38: Low dose group – Brain NA, PCB 77 & PCB 180 concentration versus heart rate sub scores 
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Figure 39: Middle dose group – Brain NA, PCB 77 & PCB 180 concentration versus heart rate sub scores 
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Figure 40: High dose group – Brain NA, PCB 77 & PCB 180 concentration versus heart rate sub scores 
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Figure 41: low dose group – Brain DA, PCB 77 & PCB 180 concentration versus grooming sub scores 
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
0.00 2.00 4.00 6.00
Br
ai
n 
co
nc
en
tra
tio
n 
(n
g/
m
l)
Time (Hours)
2 mg/cu.m
Dopamine Brain PCB 77 Brain PCB 180 Grooming
 
 
Chapter 6          Results & Analysis  
 
98 
 
 
Figure 42: Middle dose group – Brain DA, PCB 77 & PCB 180 concentration versus grooming sub scores 
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Figure 43: high dose group – Brain DA, PCB 77 & PCB 180 concentration versus grooming sub scores 
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Figure 44: low dose group – Brain 5-HT, PCB 77 & PCB 180 concentration versus Restlessness sub scores 
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Figure 45: Middle dose group – Brain 5-HT, PCB 77 & PCB 180 concentration versus Restlessness sub scores 
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Figure 46: High dose group – Brain 5-HT, PCB 77 & PCB 180 concentration versus Restlessness sub scores 
-200.00
-100.00
0.00
100.00
200.00
300.00
400.00
500.00
600.00
700.00
0.00 2.00 4.00 6.00
Re
st
le
ss
ne
ss
Time (days)
16 mg/cu.m
Serotonin Brain PCB 77 Brain PCB 180 Restlessness
 
 
Chapter 6                                                             Results & Analysis  
 
103 
 
 
Figure 47: Chromatogram showing retention times (Rt) of PCB analytes on 
UPLC-DAD 
Chapter 6                                                Results & Analysis  
 
104 
 
 
 
 
Figure 48: Chromatogram showing retention times (Rt) of monoamine 
analytes on HPLC-FLD 
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CHAPTER 7: Discussion 
The study aims to identify and characterize the neurobehavioral 
and cognitive dysfunctions caused by inhalation exposure to 
Aroclor 1232, an environmental pollutant, in graded geometrically 
progressive doses. To achieve this objective, a 11-domain 
inventory was used for scoring the neuro-behavioral functions, 
before and hourly during occupational exposures to the mixture in 
a mouse inhalation chamber (Irwin, 1968). The key results for 
behavioral effects of the PCB mixture include a decline in mood, 
autonomic and miscellaneous domain sub-scores, in a dose 
dependent and time dependent manner at each dose level, being 
contributed significantly by alteration in certain sub domains.  
In PCB-induced mood alterations, reduction in grooming and 
restlessness contributed the maximum compared to the other three 
sub-domains in mood. The autonomic dysfunction was 
significantly related to PCB exposures due to reduction in 
urination, heart and respiratory rates, and, palpebral opening 
scores, out of the eleven sub domains in autonomic 
functions.Miscellaneous functions were also altered due to PCB 
exposures mainly by reduction in exploration by mice and their 
social behavior, as compared to aggressive behavior. 
Chapter 7                                                               Discussion 
 
 
-------------------------------------------------------------------------------------------------------------------------------------- 
106 
 
The clinical correlates of grooming behavior in animals are 
Obsessive-compulsive disorder and autism like disorders (Joy, et 
al., 2002). The human correlates of self-licking, grooming and 
rearing young ones in rodents are self-cleansing endo-phenotypes 
like trichotillomania and self-mutilation, representing severe 
OCD-spectrum disorders. The neurotransmitter basis of reduced 
grooming is due to decreased dopamine release in the 
hypothalamus and amygdala, which usually occurs in stress-
induced anxiety states. Although strain differences in social 
behaviors have been reported due to variations in catecholamine 
levels in brain regions in rodents (Dwight Krehbiel, et al.,1986), 
grooming correlates well with 5-hydroxytryptamine (hyperactive 
in OCD) and dopamine (inactive in OCD) in the OCD-circuit, 
connecting through glutamate neurons (hyperactive in OCD) in 
the orbitofrontal and ventromedial striatal cortex with basal 
ganglia and anterior cingulate cortex (Greer, et al, 2002). The 
reduction in mood scores reached the trough on days 2, 4, 6 and 7 
in higher doses, being contributed by grooming decline (figure 
17). On each day of exposure, grooming reduction reached the 
trough on hours 3 and 4 in higher doses, contributing significantly 
to reduction in total behavior scores (figure 16), when the brain 
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concentrations of PCB 77 were maximal, as indicated by higher 
Cmax and lower Tmax (Tables 7-9). In the intense pharmacokinetics 
study, the brain serotonin concentration reached peak levels at 4 
hours within the first 6-hour exposure period in highest dose level 
(figure 34). At the same timepoint of 4 hours, brain dopamine 
concentrations were minimal, correlating well with the total PCB 
77 and PCB 180 brain concentrations reaching peak brain levels 
(figures 41, 42, 43) in dose dependent manner. Although 
grooming and similar compulsive behaviors are ubiquitously 
exhibited in all mammalian species, it is expressed early and more 
frequently in mice, where, it comprises of four stages – an elliptic 
stroke, a unilateral stroke followed by a bilateral stroke and lastly 
by a body licking phase IV (Berridge, et al., 2005). Increased 
grooming is expressed by mice in response to novel stimulus, and 
social interactions, and barbering mice usually are observed to be 
isolating themselves, indicating stereotypy in social isolation 
(Peter Canavello, et al., 2013). The decline in grooming in this 
study at 2-4 hours after exposure initiation hence is not due to 
introduction of mice to novel environment of chamber, and can be 
ascribed to be influenced only by the PCB induced 
neurotransmitter changes in brain. In addition, genetic mutants of 
Chapter 7                                                               Discussion 
 
 
-------------------------------------------------------------------------------------------------------------------------------------- 
108 
 
Hoxb8 gene exhibit excessive grooming and self-licking behavior 
(Greer, et al., 2002). This Hox or homeobox containing complex 
is known to contain several transcription factors thought to 
regulate neurodevelopmental stages in mammals, expressed in 
primitive streak and important for certain behavioral 
endophenotyping in vivo including compulsive behaviors.  This 
becomes an important reason for decline in grooming scores after 
trans-lactational transfer of PCBs in the F1 generation, as 
identified in this study. As a summary, the decline in mean 
grooming scores can be explained by reduced release of dopamine 
in hypothalamus and amygdala as usually hypothesized in stress 
induced anxiety disorders like Obsessive compulsive disorder 
(OCD) and autism (Figure 49).  
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Figure 49: Mechanism of reduced grooming in relation to study 
findings 
One of the interesting results of this study was a decline in 
restlessness scores on days 6 and 7 of exposures in a dose 
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dependent manner. The decline was greater at third and fourth 
hours on days 6 and 7 (figure 16). This decline occurred when the 
brain serotonin level was highest. At this timepoint, the total brain 
PCB 77-PCB 180 concentrations and their Cmax in brain were 
maximum (figures 44-46). Also, the primary metabolite of 
serotonin, 5-HIAA levels in brain were also highest at this 
timepoint when restlessness reached a trough (figures 35-37). 
Restless leg or Willis–Ekbom disease is a sensory-motor illness 
with circadian component. The behavioral endophenotypes of 
Restless leg syndrome is noted as wandering purposelessly, 
screaming, eating disorders, Munchausen syndrome (wanting / 
demanding increasing attention for proxy), cursing, pacing and 
drug induced withdrawal states, and is regarded as fidgeting 
behaviors (Perminder Sachdev, et al., 1996). Clinical criteria for 
diagnosis of RLS include paresthesia, motor restlessness, 
worsening of symptoms with relaxation, and circadian variability, 
with any of the following associated features – sleep disturbance, 
periodic limb movements in sleep, dyskinesia, and a strong family 
history of Restless Leg Syndrome (RLS). Two neurotransmitter 
mechanisms are involved in restlessness –serotonin in ventral 
tegmentum, and dopamine in the striatal cortex. Reduced 
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serotonin acting on cortico-subcortical circuits leading to 
increased dopamine release and action on inhibitory D2 receptors 
in the ventral tegmentum, as seen in a range of neurotic and 
psychotic disorders, can increase restlessness. In the striatal 
cortex, H3 receptors lie near D1 and D2 rich neurons, and 
activation of H3 receptors here can lead to inhibition of histamine-
induced excitation and release of dopamine activating D1 and D2 
receptors – this is inversely correlated with locomotor activity and 
motor restlessness (Regina Patrick, 2009). H3 activation also leads 
to release of GABA and inhibition of Glutamate in the striatum, 
leading to reduced motor activity and relief of restless leg 
syndrome in rodents and humans, respectively. In this area, 
histamine can induce increased dopaminergic neurotransmission 
and can increase its effects on D1 receptors, as compared to D2 
auto receptors, causing reduction in restlessness. For example, in 
restless leg syndrome which is a human correlate of restlessness in 
rodents, a deficiency of dopamine D2 receptors due to H3 over 
activity was noted (Glasauer 2001). Also, Btbd6 single nucleotide 
polymorphisms are thought to be responsible for abnormal 
temperature and motor activity relieved by dopamine D1 agonists 
like Ropinirole (Mark P. DeAndrade, et al., 2012). Mice with 
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mutations in Btbd6 gene exhibited reduced slow wave sleep, 
increased iron levels in serum, and reduced 5-HIAA levels in 
striatum, along with increased restlessness. Metabolically, 
increased restlessness can lead to re-organizing neural circuitry by 
increasing glutamate-stimulated glycogenolysis in astrocytes and 
increased ATP levels through reverse Warburg effect in areas 
high in anaerobic glycolysis, like the basal ganglia (Marcus E. 
Raichle, 2015). Interestingly, in hippocampus and the temporal 
cortex, which are involved in learning and memory, and cognitive 
functions, the aerobic glycolysis is low intrinsically, and hence, 
increased restlessness does not lead to or result from increased 
cognition in these areas via glutamate induced LTP. Hence, the 
primary abnormality in RLS is in the serotonin-dopamine balance 
in the descending dopamine pathways and secondarily in opioid 
system (FE Glasauer, 2001). RLS shown high incidence rate 
during pregnancy and is thought to be due to metabolic 
imbalances in this state. In this study, increased restlessness was 
exhibited by pregnant mice exposed to the PCB mixture. In 
summary, after initial phase of distribution in the brain from lungs 
and blood, PCB 77 cause increased turnover of serotonin (5-HT) 
in neurons and accelerated metabolism of 5-HT, altering the 5-
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HT:5-HIAA ratio in the striatum to cause reduced restlessness in 
mice exposed to Aroclor 1232 (Figure 50), displaying the final 
phenotypes arising from decreased action of dopamine on D2 
receptors in the corticocortical excitatory circuits. 
 
Figure 50: Mechanisms behind reduced restlessness and the study 
findings correlated with these mechanisms 
 
In the autonomic domain, notable reductions in palpebral aperture, 
heart rate, respiratory rate, and urination were significantly 
contributing to reduced autonomic function in mouse exposed to 
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high doses of PCBs, at hours 3, 4, and 5 on most days of exposure 
period (figure 20, 21, and 22). Minimal reduction of the palpebral 
aperture was noted in this study after exposures to sub-acute doses 
of Aroclor 1232. Central Nervous System depressants such as 
alcohol cause closure of palpebral opening whereas Central 
stimulants like opioids and amphetamines, and conditions like 
thyrotoxicosis cause signs of broadening of palpebral aperture like 
exophthalmos. The molecular mechanisms behind altered 
palpebral aperture can be central (direct and indirect) or peripheral 
(local and endocrine). Peripherally, the mouse Meibomian glands 
are highly expressive of muscarinic m-AChR’s 1-5, NY1R for 
Neuropeptide Y, Substance P receptor and VIP1 receptor (Hong-
Yuan Zhu, et al., 2015), where the corresponding 
neurotransmitters regulate eyelid size, thickness and other 
glandular functions. Also, in the palpebral conjunctiva and the 
adjoining eyelids, the oxygen tension is 55 ± 5 mm Hg and 
saturation is only 7.7%; i.e., the atmosphere is hypoxic (Nathan 
Efron, et al., 1979). In the rat conjunctiva, the cellular membranes 
also exhibit altered ionic fluxes especially of sodium (Dongfang 
Yu, et al., 2012), which can modulate fluid dynamics in the 
eyelid. Moreover, in the endocrine-based disruption, PCBs can 
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decrease the serum levels of thyroid hormones by displacing 
thyroxine from serum albumin, causing decrease in their actions 
in the thyroid gland, leading to hypothyroidism in many clinical 
studies (Kodavanti, et al., 2003). Additionally, PCBs induce the 
tissue type (hepatic) deiodinases which normally increase 
peripheral formation of the more potent triiodothyronine, leading 
to thyrotoxicosis in chronic use. In the CNS, although thought to 
be not directly caused by altered arousal mechanism, the 
neurotransmitter mechanisms involved in cortical arousal like 
antagonism of Gamma Amino Butyric acid (GABA) and 
stimulation of 5-Hydroxytryptamine and histamine are thought to 
increase the aperture in rodents, as opposed to sedation (Nicholas, 
2008; Megens, 2013). Direct Central effects can also cause 
palpebral aperture changes due to PCBs. In this study, the Cmax of 
PCB 77 and PCB 180 reached maximum in brain at 3-5 hours of 
exposures, when the palpebral opening size reduced greatly 
(tables 7-9). From the concentration-time (cxt) profiles of 
serotonin in brain, it is apparent that this neurotransmitter reached 
peak brain levels at 6 hours across all doses of PCBs (Figures 32-
34), supporting the central anti-arousal mechanism of palpebral 
aperture reduction. Additionally, PCBs acutely stimulate, and sub 
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acutely depress the central nervous system (US-EPA, 2000), 
indicating the direct central depression as the basis for this effect. 
This reduction in the aperture size can compensate for the hypoxic 
conditions caused by the inhalational PCB exposures in the 
already low oxygen tension environment of the palpebral 
conjunctiva, to serve a protective role in the exposed mice. 
Finally, their effects on thyroid hormones may not account for all 
the observations on palpebral opening in the exposed mice. This is 
because both hypothyroidism and hyperthyroidism can cause 
myxedema and increased palpebral aperture (R. S.Mahto, 1972). 
But both coplanar and non-planar PCBs can reduce thyroid 
hormones (Kodavanti, 2005), and this is the first report of these 
pollutants causing reduction in palpebral opening. Hence, this 
effect may be due to central actions of PCBs on neurotransmitters 
(Figure 51).  
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Figure 51: Mechanisms behind reduced autonomic functions due 
to decreased palpebral opening 
After Aroclor 1232 exposure, there was a depressant effect on 
heart rate at 2 hours on all exposure days across all dose levels 
(figure 16). The negative chronotropic effects of PCBs may be 
due to cardiac, reflex, and central depression. Heart rate is 
regulated by beta adrenoceptors in SA nodes; by ganglionic 
cholinoceptors and via central physiological reflexes; and in the 
cardiovascular centers in the medulla.It can be hypothesized that 
PCBs may act through any of these targets to cause such effects. 
For example, vagal tone dominates over sympathetic tone to 
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control heart rate (Swoap, 2008), and circadian inputs from the 
suprachiasmatic nucleus is also regulating animal behavior in 
heart rate regulation (Sheward, 2010). Physiological in vivo Heart 
rate measurements in adult C57 b mice, such as used in this study, 
have a heart rate of about 502 beats/ minute and hemodynamic 
measurements result in mean heart weights of about 202 mg in 
mice weighting 34 grams (Pieter A., et al., 1998). For heart rate 
modulation, sympathetic tone predominates in mice and beta 
blockade produces bradycardia and large heart rat variability, 
similar to stimulation of baroreceptors in mice (Josef Gehrmann, 
et al., 2000) although at thermoneutrality when heart rate is basal, 
vagal tone overcomes as the predominant autonomic regulator in 
mice (S. J. Swoap, et al., 2008).In isolated mouse atrial 
preparations, heart rate changes were observed to be due to altered 
hyperpolarization activated currents, L-type calcium currents and 
potassium-acetylcholine driven currents in the SA node (J. K. 
Choate, et al., 2003). Additionally, brain type tetrodotoxin 
sensitive VGSCs are also important in the regulation on heart rate; 
blockade of this channel, which is normally localized in non-nodal 
atrial tissue, produced signs of sick sinus syndrome in animal 
models (Sebastian K. G. Maier, et al., 2002), in a manner similar 
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to ryanodine channel (RyR2) gain-of-function mutations in SA 
node (Michael J. Bround, et al., 2012). Metabolic error-induced 
autonomic dysfunction like diabetes can lead to cardiac 
remodeling and altered chronodynamic control, such as those 
induced by PCBs in this study, but in a chronic timeline; for 
instance, diabetes induced increased cholinergic receptor density 
in the SA node and negative chronotropic effects after 
administration of streptozotocin (Abigail M. Mabe, et al., 2011). 
The same effect happens in a polymorphism (SNP) observed in 
the gene for HCN channel in the SA node, reducing cAMP 
dependent depolarization of sympathetic neurons (Jacqueline 
Aliga, et al., 2009); and deletion of neurturin that is a neurotrophic 
factor for cholinergic neurons which causes positive effects on 
depolarization through loss of cholinergic control of heart rate 
(Anthony M. Downs, et al., 2016). NOS-induced and neutrally 
regulated norepinephrine synthesis in SA node can lead to 
positive chronotropic effects by depolarization through activation 
of SA nodal beta receptors (Choate, et al., 2007). In this study, 
norepinephrine levels in brain was minimal at 2 hours after 
exposure initiation suggesting a base for heart rate reduction 
(figures 38, 39, 40). This is also the time when PCBs are about to 
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redistribute from blood to the brain after being absorbed from the 
alveoli.As a summary, when PCBs 77 and 180 redistribute to 
brain from plasma, i.e., when their plasma concentrations are 
maximum at 2 hours, they reduce brain norepinephrine levels 
(which also correlate well with peripheral levels) causing negative 
chronotropic effect (Figure 52). 
 
Figure 52: Negative chronotropy caused by PCBs and their 
mechanisms 
In this study, Respiratory rate reduced at 4 hours of daily 
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exposures especially in high dose exposures. Certain anatomic 
and physiologic differences are important between mouse and 
human lungs for risk assessment. The parenchyma of mouse lung 
occupies space in relation to its body surface area that is 
intermediate between human and rat; the alveoli of mouse lung 
are smaller than human alveoli; the total lung capacity is 1 ml; 
about 1/5000th of human beings and 1/10th of rat lungs. The mouse 
lung has two sides – like in humans, the right lung has five lobes 
but unlike human lungs, the left mouse lung has only a single 
lobe. At physiological inflating pressures of 30 cm H2O, the 
mouse pleura, which is thinner than in humans, is still inflatable. 
The blood-gas barrier is half that of humans (0.62 microns); the 
airways comprise greater proportion of mouse respiratory tract 
and the cartilage is less well organized in mouse trachea than 
human thorax; mouse epithelial lining of airways is thinner and 
the airway lumen larger than humans, the bronchial divisions is 
monopodial in mouse as compared to dichotomous divisions in 
humans; all these differences allow the mouse to have a greater 
basal respiratory rates of 250-350 bpm (Charles G Irvin, et al., 
2003) due to lesser resistance to the impeding airflows.Although 
neural control of respiration (vagal tone) is well established 
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(Hideki, 2007), emerging evidence such as vasopressin V2a and 
other neuroendocrine mediated regulation cannot be 
underemphasized (Crone 2012). Generally, curariform drugs 
inhibiting nicotinic receptors in diaphragm and reflexely acting, 
and central depressants like opioids, antihistamines and 
acetylcholine depress respiratory rate. Higher exercise rates in 
mouse can even reduce this rate over a long time (Mandi 
McGoyne, 1999). For instance, in human patients, increase in 
tidal CO2 inspiration in controlled and experimental set ups, 
caused increased heart rate variability due to autonomic 
interaction in the CNS (M. Poyhonen, 2003). Peripheral and 
central cardiorespiratory reflexes such as baroreceptors 
controlling RR in mouse can have two components – a baro-vagal 
and a baro-sympathetic component, the former is more important 
for BP control in mice (Colin N. Young, et al., 2011). Centrally, 
opioid injection into raphe magnus regulated cardio-respiratory 
functions in mice (Kevin M. Hellman, et al., 2009); this area is 
thought to regulate the balance between the two autonomic 
systems in cardio-respiratory control by the CNS. Also, the 
hypoglossal nerves containing 5-HT neurons mediate respiratory 
plasticity in many invertebrates and vertebrates; GABA and non-
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GABAergic influences of respiratory center development have 
been identified in rodents (GS Mitchell, et al., 2001). Vagal 
control of respiratory clocks in mice are known to be influenced 
by expression of cholinergic receptors specific genes – Chrm-
2,3,4 in suprachiasmatic nucleus in a diurnal pattern (Hideki 
Bando, et al., 2007).In this study, serotonin levels increased, and 
norepinephrine levels reduced when respiratory rate was 
minimum and PCB brain concentrations were starting to increase. 
Hence, central respiratory center depression could be implicated 
in the reduced respiratory function due to reduced norepinephrine 
levels, apart from the physiological effects of the inhalational 
exposures (Figure 53).  
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Figure 53: PCBs negative effects on RR and their putative 
mechanisms 
The hypogastric nerve containing beta adrenoceptors 
inhibits the detrusor and M2 muscarinic receptors releasing Nitric 
Oxide (NO) inhibits the smooth muscle of the bladder, causing 
relaxation when stimulated (Warren, 2014). Cholinergic co 
transmitters like ATP and alpha adrenoceptors stimulate 
micturition reflex. Centrally the pontine micturition center and the 
Periaqueductal Grey are involved in this reflex (Clare J. Fowler, et 
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al., 2008). Dopamine elicits inhibitory effects on micturition 
through activation of D1 and 5HT1A receptors and inhibition of D2 
receptors. Parkinson’s disease patients having degenerative 
dopaminergic neurons in the basal ganglia and suprapontine areas 
have reduced bladder capacity and detrusor overactivity due to 
removal of inhibitory control on the bladder. Spinal cord injury 
causes initial urinary retention followed by features of neurogenic 
bladder and automatic but incomplete voiding due to detrusor-
sphincter dyssynergia. Noradrenaline, acting through beta 
receptors, is inhibitory on the bladder function and reduces 
bladder voiding reflex, through hypogastric nerve fibers (Clare J. 
Fowler, et al., 2008). Urinary levels of neurotransmitter and their 
metabolites have been used as biomarkers for diagnosis of ADHD 
and major depression informally (David T. Marc, et al., 2011). 5-
hydroxytryptamine produces relaxation of urinary bladder as a 
part of non-adrenergic non-cholinergic transmission in the 
autonomic neurons (G. Burnstock, 1986). Urothelial increase in 
cellular calcium can lead to bladder contraction (Warren G. Hill, 
2015) – since PCBs can alter calcium in neurons and smooth 
muscle cells, it may be possible mechanism for PCBs to cause 
reduced micturition, especially the slow component, as observed 
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in high dose in this study (Figure 54). Calcium antagonists can 
also cause a similar effect to PCBs as observed in earlier studies 
(M.B. Bhat, et al., 1989).  
 
Figure 54: Mechanisms of inhibitory effects of high dose PCBs on 
urination 
The effects of PCBs on miscellaneous domains like increased 
social isolation and reduced exploration could be ascribed 
mechanistically to the inhibition of monoamine release in the 
raphe nucleus, basal ganglia (Nucleus accumbens) and cerebellum 
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(Foster, 2014). This area is rich in Serotonin; indeed, SERT 
knockout mice can express aberrant spatial-temporal responses in 
novel environment, like perseverance-related behaviors in human 
depression (Allan V. Kalueff, et al., 2007).  
The plasma and brain PCB 180 did not reflect on the behavioral 
scores during the pharmacokinetic study timepoints. It may be due 
to the higher lipophilicity and cumulation of PCB 180 leading to 
more bioaccumulation that it does not correlate with the sub-acute 
effects assessed in this study (Espen-Johanssen, 2011). 
Gestational exposures to the dioxin-like PCB 77 reduced body 
weight gain during first 6 days of life of litters, and higher doses 
increased litter mortality and grooming-licking behavior of 
offspring rats – altering maternal behavior in rodents (Simmons 
SL, et al.., 2005). In addition, PCB 77 treatment reduced the time 
the dams spend on the nest in this study.   
Novelty preference test (NPT, Y maze) evaluates spatial 
associative memory in rodents, the memory task performance 
improved by stimulating metabotropic glutamate control of 
inhibitory dopamine output in striatum, and hippocampus 
(Magdalena, 2016). Neuroimmune mechanisms can disrupt the 
spatial memory performance through purinergic receptors and 
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interleukin 1 β in the hippocampus (Virginie, 2009). The Y maze 
spontaneous alternation test assesses spatial working memory in 
rodents, zebrafish and drosophilia (Sara, 2017). Glutaminergic 
and cholinergic transmitters are thought to be involved in this 
process. In the present study, there was significant reduction in 
alternation indices across increment in doses of Aroclor 1232.  
The elevated plus maze transfer latency duration is directly 
proportional to anxiogenic effect and is thought to involve 
monoamines in the brain and GABA (Alicia, 2007). The Open 
Field test assesses spontaneous motor activity in rodents and is 
thought to involve increased presynaptic serotonin-dopamine 
interaction in both striatum and nucleus accumbens of the reward 
circuit (Patricia, 1997) and is thought to be a correlate of drug 
addiction and locomotor activities. Being coplanar, PCB 77 
probably contributes to neurotoxic effects in many of these 
paradigms by depressing long term potentiation in the 
hippocampus (Mete Ozkan, 2005). 
Histopathology staining of neurons with H & E showed focal 
increase in darkly staining neurons in high dose levels, probably 
implying apoptotic cells (Ishida K, 2004). The cerebral cortices 
showed signs of mature neurogenesis and inhibiting of neuronal 
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apoptosis by activating bcl2 pathway and inhibition of 
proapoptotic caspases as a response to local hypoxia created by 
PCB inhalation (Volbracht, 2001). High dose, 16 mg/cu.m 
showed intermediate level of positivity for both Bcl 2 and Bcl 6 
cells in the cerebellum – these indicate neuronal overexpression of 
bcl 2 and bcl 6, implying an increase  in the number of neurons in 
the cerebral and cerebellar cortices in treated mice, probably by 
inhibiting naturally occurring neuronal apoptosis, and also 
increase in mature neurogenesis in cerebral and cerebellar cortex 
of treated mice, respectively (Rizwan, Akhtar S, et al., 2004; Luca 
Tiberi, et al., 2012, respectively). ER alpha showed increased 
cytoplasmic positivity in cerebrum of this dose level, probably 
implying   a switch   over to neuropathologic phenotype (Andon 
H, et al., 2004). Anti-apoptotic NDL-PCBs (PCB 153) can be 
effected through Thyroid hormone receptors in the pituitary, 
whereas, the pro-apoptotic phenotype of NDL-PCBs like PCB 
180 is effected through AhRs in the pituitary gland; PCB 77 and 
other DL-PCB congeners did not affect oncogenic pathways in 
pituitary tumorigenesis in one report (Francesco Raggi, et al., 
2016).  
A definite depression of behavior in offspring generation was seen 
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compared to parent generation owing to higher transfer of PCBs 
across lactational route, as concluded in earlier studies (Paola 
Pocar, 2011). From the study, there does not seem to be any 
transfer of PCBs through placenta probably due to their higher 
lipophilicity. This agrees with earlier studies that PCBs tend to 
persist more in milk than other body fluids in rodents and cause 
neurodevelopmental effects in offsprings of exposed mothers 
(Curran, 2011). The effect of such short duration of exposure on 
PCB 180 transfer by other dosing routes across one generation has 
also been discussed earlier by other studies in rats (Matti 
Viluksela, 2016). In addition, PCB 77 diminished normal adult 
sexual partner preference in rats treated during gestation and post-
natal period orally, though it did not affect sexual behavior, and 
this effect dependent whether the exposure was in-utero or 
translactational, and was independent of any other behavior 
phenotypes (Cummings JA, et al., 2009). PCB 77 exposure during 
pre-natal period in maternal rodents altered maternal behavior 
including increased maternal nursing, and amount of maternal 
auto grooming.  Increased time spent in nest, increased pup 
grooming frequencies, reduction in high crouch nursing and pup-
maternal interactions were both due to maternal in utero and post-
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natal exposure to PCB 77 (Cummings JA, et al., 2005). Such 
changes were also ascribed to altered preference to maternal odor 
although the preference to novel odors did not change, after 
exposure to PCB 77, a process called ‘odor conditioning behavior’ 
(Cromwell HC, et al., 2007). PCB 77, the most toxic DL PCB can 
reduce Thyroxine both peripherally and centrally in key stages of 
neurodevelopmental differentiation in chicken, whereas, more 
abundant o-substituted NDL-PCBs like PCB 153 and 180 did not 
affect thyroid hormones – a key mechanism for neuro endocrine 
disruption caused by PCBs developmentally (Martha León-Olea, 
et al., 2014).  Both PCB 180 and PCB 77 caused increased 
mobilization of hepatic retinoid stores with increased renal 
retinoid acid levels with reduced thyroid hormone levels; this is of 
key importance in neurodevelopmental processes since retinoic 
acid derivatives are lipid derived antioxidants (Matti Viluksela, et 
al., 2014).  
Heavy-chlorinated PCBs mix administered gestationally in rats 
reduced the drive for social motivated behavior such as maternal-
pup and sexual behaviors and increased sexual dimorphism by 
reducing the expression of and binding of NMDA-R in cortical 
areas without a change in hippocampus. Aroclor 1254 treatment 
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reduced expression of glial glutamate transporter in the striatum 
and hippocampus of treated adolescent rodents, and Dopamine 
transporter binding in striatal cortices of male rats. In addition, 
NDL PCBs reduced Dopamine tissue content and increased its 
extracellular levels in the striatum in-vitro. PCB 153 reduced D1 
receptor density in the cortex and striatum, and reduced D2 auto 
receptor affinity in the striatum. PCBs also reduced dopamine 
synthesis and release in the cortices of animals treated orally. All 
these mechanisms are thought to be responsible for the endocrine 
disrupting effects of PCBs on social and sexual behaviors in 
rodents and humans (Margaret R Bell, 2014).  
Recent analysis suggests that higher the chlorination, a greater 
reduction in such PCB or Aroclor induced Monoamine metabolite 
levels like homo-vanillic acid in serum within 14 days of 
treatment, leading to hypothesize that these PCBs do play a 
significant role in altering brain monoamine neurodynamics 
(Franziska Maria Putschög, et al., 2015). PCBs and brominated 
phenyl ethers (BDEs) exposures have important effects on 
neuronal differentiation into neurotransmitter phenotypes when 
the exposure has taken place prior to or during key periods of 
neurodevelopment, which can also alter monoamines like 
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dopamine in brain regions (Theodore A. Slotkin, et al., 2013).  
PCBs having high lipophilicity and hepatic extraction ratios 
(Claude Emond, et al., 2005) can induce cytochrome P450 
enzymes in liver including CYP1A and CYP2B superfamily of 
enzymes, causing reduced activities of steroid synthesizing 
enzymes and aromatases, thereby causing endocrine disruption. 
Such PCBs are also producing disrupting effects on spatial 
alternation paradigms in rodents and monkeys through similar 
mechanisms (Edward D. Levin, et al., 2004), which are 
potentiated by other intoxicants including methylmercury. 
Although PCBs can pass through physiological barriers like 
blood-brain and blood-placental barriers, they are not 
concentrated in fetal tissues, although they can be concentrated in 
brain areas (HB Matthews, 1984).  
A mechanism of PCB induced neurotoxicity is hypothesized in 
the following figure, based on the study findings and a thorough 
literature review (Figure 55).  
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Figure 55: A model for PCB induced neurotoxicity in mice 
Distribution into brain (3 hours) and redistribution out (4-5 hours) and elimination (metabolism and excretion - after 5 hours)
AROCLOR 1232 (repeated dose - inhalational route)
COPLANAR, DIOXIN LIKE - PCB 77 NON DIOXIN LIKE - PCB 180
PCB 77
Partial agonist-antagonist of aryl 
hydrocarbon receptors [midbrain]
reduced mibrain dopamine 
function - pro-depressive action
Reduced excitatory output from 
Cortex & increased output from 
striatum - Reduced social 
motivation
Reduced GnRH from pituitary  due 
to reduced glutamate & kisspeptin -
Disrupted endocine axis
FSH-LH mismatch from pituitary -
Endocrine disruption
Reduced levels of circulating 
thyroxine, estrogen and 
progesterone - decreased mating 
by females, weight loss in offsprings
Aroclor 1232
hydroxylated metabolites of PCBs
Stimulate Ryanodine receptors
Increased PKC translocation into 
cytosol
Inhibition of calcium uptake into 
microsomes and mitochondria
Reduced astrocyte to glia 
differentiation
Increased susceptibility to stress
PCB 180
Antagonize Estrogen receptors & 
aryl hydrocarbon receptors in brain
Increase intracellular calcium and 
PKC-PKA activities
Reduced striatal dopamine levels
Synergizes with other intoxicants 
(e.g. methylmercury)
Increased reactive oxygen species 
(catechol based)
Neuronal cell death
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CHAPTER 8: Summary 
 
1) Low dose did not produce significant change in behaviour: A 
dose of 2 mg/cu.m dose did not produce statistically 
significant change in behavioural scores compared to the 
control group at all timepoints of exposure. 
2) Behavioural scores indicative of central depression in 
intermediate dose: The mean behaviour scores was reduced 
at 4 mg/cu.m dose on day 6 of exposure, which was a 
statistically significant difference compared to control group. 
3) Behavioural scores indicative of central excitation at high 
dose: The mean behaviour scores were increased at 16 
mg/cu.m dose on days 6,7 and 8 of exposures, which was 
statistically significant difference compared to the control 
group. 
4) Behaviour changes maximally at 3-5 hours of exposure: The 
trough in the total behavioural scores reached a maximum 
change at 3 and 4 hours in all dose levels and at 5 hours in 
intermediate dose levels. The Mann Whitney U-test revealed 
statistical significance for these time points of test groups, 
compared to those in control group. 
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5) Trend of total behavioural score across days: A temporal
trend was not observed in the change of mean behavioural
scores across days such as that observed across hours. The
direction of change of mean hourly behavioural scores at
each hour was inconsistent.
6) Contribution of domain sub scores to the temporal trend
across hours: Mood, autonomic scores and miscellaneous sub
domains were significantly different from control group
scores in these domains.
7) In the neuro-cognitive paradigms, the y-maze alternation test
showed significant differences across dose levels of aroclor
1232 treatment.
8) The brain monoamine levels were estimated by HPLC-FLD
method for three parents (Dopamine, norepinephrine,
epinephrine) and two metabolites (DOPAC, 5-HIAA).
9) Generally, the behavioural domains correlate with
monoamine reductions in pharmacokinetics study time-line.
10) The neuro-cognitive indices correlate with monoamine
increases in toxicokinetics time-lines.
11) PCB 77 and PCB 180 were significantly detected using
UPLC-DAD in both plasma and brain samples across all
dose levels.
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12) The findings of neurotoxicity were confirmed in H&E
histopathology of brain areas (cortex, cerebellum and
hippocampus). Additionally, compensatory neurogenetic
responses were observed in BCL2/6 IHC and estrogenic
effects of PCBs were confirmed in ER-alpha IHC staining.
13) The PCBs were significantly responsible for reduction in
behavioural scores in translactational group in the one-
generational toxicity study.
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CHAPTER 9: Conclusion 
• Polychlorinated Biphenyls produced neurobehavioral functional 
and structural toxicities in mouse in a dose dependent and time 
dependent manner when exposed to Aroclor 1232 via the 
inhalational route.
• There was significant inter-generational toxicity of PCBs on 
behavioural scores, after transfer by translactational route.
• These toxicities if proven in further studies can be extrapolated to 
human indoor occupational hazard risk assessments. 
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CHAPTER 10: Impact of the study 
 The study focusses on the occupational exposures of animals to 
PCBs’ neurobehavioral toxicity which can be extrapolated to 
workplace indoor hazards e.g. electronic manufacturing units, 
machinery units, etc. wherein workers may be exposed to these 
unintentional pollutants by inhalational route
 The study brings out the neurobehavioral toxicities across one 
generation of mice, comparing the effects of PCBs on diverse 
neuronal functions between parent mice and offspring mice 
exposed to PCBs via different routes
 The neurobehavioral toxicities of Aroclor may correlate with PCB 
77 and 180 concentrations in plasma and brain which can be used 
as surrogate biomonitoring markers in human risk assessments 
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A simple, sensitive and reproducible ultra‐performance liquid chromatography (UPLC)
method has been developed and validated for simultaneous estimation of polychlorinated
biphenyl (PCB) 77 and PCB 180 in mouse plasma. The sample preparation was performed by
simple liquid–liquid extraction technique. The analytes were chromatographed on a Waters
Acquity H class UPLC system using isocratic mobile phase conditions at a flow rate of 0.3mL/
min and Acquity UPLC BEH shield RP18 column maintained at 35°C. Quantification was
performed on a photodiode array detector set at 215 nm and PCB 101 was used as internal stan-
dard (IS). PCB 77, PCB 180, and IS retention times were 2.6, 4.7 and 2.8min, respectively, and the
total run time was 6min. The method was validated for specificity, selectivity, recovery, linearity,
accuracy, precision and sample stability. The calibration curve was linear over the concentration
range 10–3000 ng/mL for PCB 77 and PCB 180. Intra‐ and inter‐day precisions for PCBs 77 and
180 were found to be good with CV <4.64%, and the accuracy ranged from 98.90 to 102.33% in
mouse plasma. The validated UPLC method was successfully applied to the pharmacokinetic
study of PCBs 77 and 180 in mouse plasma.
KEYWORDS
mouse plasma, PCB 180, PCB 77, pharmacokinetics, UPLC‐dad1 | INTRODUCTION
Polychlorinated biphenyls (PCBs) are a chlorinated class of chemicals
that are divided into 209 congeners grouped across 10 homologs
(US‐EPA, 1989). They are emerging as persistent pollutants in the
environment although their production has been restricted in many
countries owing to their high lipophilicity and ubiquitous nature
(UNEP, n.d.). Two such biphenyl congeners, viz. PCB 77 and PCB
180, have contrasting and unique physicochemical and toxicological
characteristics. PCB 77 is a coplanar dioxin like tetra‐chlorobiphenyl
congener, while PCB 180 is a nondioxin‐like congener with greater
lipophilicity. PCB 77 is low chlorinated congener (Agency for Toxic
Substances and Disease Registry, 2000), whereas, PCB 180 is
heptachlorobiphenyl with more chlorination of biphenyl nucleus
(Viluksela, Heikkinen, van der Ven, Rendel, & Roos, 2014). Since
PCB 77 is planar with a small dihedral angle (Dasary, Saloni, Fletcher,wileyonlinelibrary.com/jouAnjaneyulu, & Yu, 2010), it is an endocrine disrupter. Moreover as it
is non‐ortho‐substituted dioxin‐like congener, it is unique among
endocrine disrupters, and also forms polar hydroxylated metabolites
(Grimm et al., 2015). PCB 180, on the other hand, is not an endocrine
disrupter as it lacks dioxin activity and is more lipophilic (Maisano
et al., 2016; Matthews & Dedrick, 1984; Saija et al., 2016). This
congener forms reactive metabolites in addition to hydroxylated
compounds (Grimm et al., 2015). In summary, PCB 77 and PCB 180
differ from a toxicological perspective – PCB 77 is a low chlorinated
neurotoxic endocrine disrupter that is more polar than the other
congener, PCB 180, which is a high chlorinated nondioxin‐like
lipophilic persistent pollutant. PCBs and other chlorinated com-
pounds can be estimated by isotope dilution high‐resolution gas
chromatography–mass spectrometry in tissues (Sather, Newman, &
Ikonomou, 2003). PCBs can also be estimated in other matrices like
air samples (Muir & Sverko, 2006), aroclor standard mixtures
(Pietrogrande, Benvenuti, & Previato, 2000), rat liver microsomes (Zhai,
Wu, Lehmler, & Schnoor, 2013), groundwater samples (Letcher, Li, &Copyright © 2017 John Wiley & Sons, Ltd.rnal/bmc 1 of 6
2 of 6 RAMANUJAM ET AL.Chu, 2005) and blood plasma (Mathews, 2014) by various gas chro-
matographic detection techniques.
Most studies on PCB 77 concentrations in environmental and
biological samples have used gas chromatographic techniques with
detection methods including mass spectrometry (Eske et al., 2014;
Ghosh et al., 2010; Wang et al., 2013) and nonspectrometric methods
(Brieger & Hunter, 1993; Chu et al., 1995). Studies employing PCB 180
as the analyte of interest have evaluated its concentrations in matrices
using gas chromatography with electrochemical detector (ECD) detec-
tion (Bogdevich & Cadocinicov, 2001; Cossu, Ledda, & Chessa, 2013;
Tian et al., 2016; Viluksela et al., 2014). Only one study (Dmitrovic,
Chan, & Chan, 2002) which has evaluated both the congener serum
levels has employed GC–MS. To date, there are only a handful of stud-
ies that have employed liquid chromatography for assessment of PCB
concentrations (Mathews, 2014; Pietrogrande et al., 2000). None
of these studies have assessed PCB 77 and PCB 180, congeners
with toxicological significance and uniqueness, simultaneously, in a
cost‐effective and time‐efficient manner employing UPLC or HPLC.
In this study, we report such a method development and validation
for PCB congeners, viz. PCB 77 and PCB 180 using a novel ultra‐high‐
performance liquid chromatographic method for simultaneous
estimation of these two PCB congeners in mouse plasma samples.
We have optimised a cost‐effective and time‐efficient method of
routine estimation of these congeners in plasma samples. Additionally,
one of the objectives of this study is to estimate the pharmacokinetic
parameters of these congeners in plasma, after occupational exposure
in mouse using a whole body inhalational chamber.2 | MATERIALS AND METHODS
2.1 | Chemicals and reagents
The reference standards of PCB 77, PCB 180 and PCB 101 (IS) were
purchased from Sigma‐Aldrich, India. Acetonitrile and methanol of
HPLC grade was purchased from Sigma‐Aldrich, India. Methyl tert‐
butyl ether of HPLC grade was obtained from Himedia, India. Ultrapure
water (18.2MΩ cm) was obtained from a MilliQ water purification sys-
tem from Millipore (Milford, USA). All other chemicals used were ana-
lytical grade.2.2 | Animals
Thirty‐two Swiss albino mice were procured from PSG animal facility
and quarantined. All animals were housed in standard housing
conditions with ambient light–dark cycle (10:14 h) and environment
(temperature of 24–26°C) with feed and water ad‐libitum. The
animals were weighed and grouped into cages randomly. All mice
were females with 18–25 g body weight. The mice were acclimatized
in the animal house for 3 days followed by acclimatization in the lab-
oratory for 2 days. Prior approval for the study was obtained from
the Institutional Animal Ethics Committee. All experiments were
carried out as per regulatory guidelines like the Organisation for
Economic Co‐operation and Development (EU), Committee for the
Purpose of Control and Supervision of Experiments on Animals (India)and Indian Council for Medical Research Guidelines for Biomedical
Research (India).2.3 | Instrumentation and chromatography
conditions
The UPLC instrument consisted of a Waters Acquity H class UPLC
system equipped with a quaternary pump and 96‐vial autosampler
coupled with a diode array UV detector (Waters, Milford, MA, USA).
The chromatographic separation was performed on an Acquity UPLC
BEH C18 column from Waters (2.1 × 100mm; 1.7 μm). The column
temperature was set at 35°C and the autosampler was kept at 15°C.
The mobile phase was composed of a mixture of acetonitrile (85%, v/v)
and water (15%, v/v) at a flow rate of 0.3mL/min. Before analysis the
mobile phase was filtered through a 0.22 μm membrane filter and
degassed by ultra‐sonication. A 5 μL injection of each sample was
loaded onto the system and total analysis time was 6min. The diode
array detector (DAD) was set at 215 nm. The sampling needle was
washed with 300 μL of strong wash (ACN–water, 65:35) to reduce
carry‐over and 300 μL of weak wash (ACN–water, 30:70). Data acqui-
sition was done using Empower 3 software version 1.0 (Waters, USA).2.4 | Preparation of stock and working standard
solution
PCB 77 and PCB 180 stock solutions of 1mg/mL were prepared by
dissolving suitable amounts of the single drug in methanol. Mixtures
of stock solutions of PCB 77 and PCB 180 (100 μg/mL) were prepared
in methanol. The IS stock solution of 200 μg/mL was prepared in
methanol. The stock solutions of PCB 77, PCB 180 and IS were stable
at 4°C for 1month. Further dilution was made in methanol–water
(50:50, v/v) to produce working stock solutions for the calibration
standards and quality control (QC) standards. The IS working solution
(5 μg/mL) was prepared in methanol–water (50:50 v/v). Calibration
curve samples were prepared in drug‐free mouse plasma with the
appropriate mixture of working solution of PCB 77 and PCB 180 on
the day of analysis. All the samples were stored together at
−80 ± 10°C until analysis.2.5 | Sample preparation
Sample preparation was carried out by the liquid–liquid extraction pro-
cedure. Into a 100 μL of aliquot of plasma, 10 μL of IS working solution
was mixed for 30 s on a spinix vortex shaker (Tarsons, India). To this,
3.0mL of tert‐butylmethylether was added and this was vortex mixed
for 5min. This was centrifuged at 10,000 rpm for 5min at 4°C on an
Eppendorf 5810R centrifuge (Eppendrof AG, Hamburg, Germany). The
clear supernatant organic layer (2.5mL) was transferred into 5mL poly-
propylene tubes and evaporated to dryness at 35°C using a nitrogen
evaporator (Turbovap®, Biotage, USA). The residue was reconstituted
in 100 μL of the mobile phase, vortex mixed for 1.0min and centrifuged
at 10,000 rpm for 5min. Finally, 90 μL of the clear supernatant was
transferred into glass micro‐vials and 5 μL was injected onto the UPLC
system for analysis.
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The method was validated for selectivity, specificity, recovery, linear-
ity, accuracy, precision and stability using US Food and Drug Adminis-
tration guidelines (US DHHS et al., 2001) for the assay in plasma.
2.7 | Carry‐over and limit of quantification
Carry‐over effect was assessed by injecting the highest calibration
standard just before blank plasma. The limit of quantitation (LOQ)
was defined as the first point of the calibration standard with lowest
concentration (signal‐to‐noise ratio ≥ 10:1) that can be calculated with
an acceptable precision and accuracy.
2.8 | Selectivity and specificity
The selectivity of the method was assessed by analyzing pooled drug‐
free mouse plasma injected at the beginning of the validation and the
potential interferences at the LC peak region for analytes and IS were
investigated. At least four out of six lots should have a response <5
times the lower limit of quantitation (LLOQ) level response in the
same matrix.
2.9 | Recovery
The recoveries of PCB 77 and PCB 180 were assessed by analyses of
the three various concentrations (30, 500 and 2250 ng/mL) whereas
the recovery of the IS was determined at a single concentration of
5 μg/mL. Recovery was calculated as the extracted spiked plasma peak
area response compared with the response obtained for neat standard
solution at equivalent concentrations by liquid–liquid extraction
process. The analytes responses from the extracted samples
at known concentrations were compared with responses of un‐
extracted standards.
2.10 | Linearity
Linearity was evaluated by linear regression analysis with the use of
working standard solutions and spiked plasma samples containing the
drugs of interest at different concentrations within the range 10–
3000 ng/mL for PCB 77 and PCB 180. The calibration curves were
constructed by plotting the ratio of the peak area of each analyte to
the peak area of internal standard vs the nominal drug concentration.
The slopes and intercept were calculated with least square linear
regression analysis of the data with the use of a 1/x2 (x‐concentration)
weighting factor. The acceptance criteria for each back‐calculated
standard concentration were ±15% deviation from the nominal value
except at the LLOQ, which was set as ±20% (US DHHS et al., 2001).
2.11 | Accuracy and precision
The validation method evaluations of the accuracy and precision in the
experiments were performed with four independent series (including
ruggedness) in plasma. The intra‐ and inter‐day assay accuracy and
precision were estimated by analyzing six replicates containing
analytes at three different QC levels, that is, 10, 30, 500 and
2250 ng/mL. Accuracy represents the closeness of agreementbetween the mean values obtained from the series of measurements
by the method and the actual value. The accuracy should be within
85–115% of the nominal value, except at the LLOQ, where it should
not deviate more than 20% (US DHHS et al., 2001). Precision repre-
sents the closeness of agreement among a series of measurements
obtained from multiple samplings and was estimated with variances
of repeatability (intra‐day variances) and intermediate precision (sum
of intra‐day and inter‐day variances). The precision should not exceed
±15% relative standard deviation (RSD), except for the LLOQ, where it
should be within ±20% of RSD (US DHHS et al., 2001).2.12 | Stability
Stability tests were performed to evaluate the stability of analytes in
plasma samples under different conditions. The bench‐top stability
study assessed the stability of analytes in plasma at room temperature
for 9 h, whereas a post‐preparative stability study assessed the
stability of analytes in the treated samples (autosampler stability for
24 h at 15°C) at low (30 ng/mL) and high (2250 ng/mL) QC concentra-
tion. Freeze–thaw stability was determined after three freeze and
thaw cycles and long‐term stability was determined by testing QC
samples stored at −80°C for 30 days.2.13 | Pharmacokinetic study
Animals were exposed to PCB 77 and 180 via inhalation at a dose of
4mg/m3 in water for 6 h in a whole body inhalation chamber. Blood
samples (150 μL) were obtained using lithium tubes with heparin, using
retro‐orbital venipuncture at 0.0 (before exposure) followed by 2.0,
4.0, 6.0, 8.0, 12.0, 24.0, 36.0 and 48.0 h after the initiation of exposure.
Whole blood samples were centrifuged at 3500 rpm for 10min and
plasma was separated and stored at −80°C until use. The areas under
the plasma concentration–time curve (AUC0–inf and AUC0–t) were used
to estimate maximum plasma concentration and time taken to reach
this concentration (Cmax and Tmax) using trapezoidal rule. The half‐life
of elimination (T1/2) was determined using linear regression with sum
of least squares method. WinNonlin software 5.1 was used to calculate
the pharmacokinetic parameters by noncompartmental model
(Pharsight Corporation, CA, USA).3 | RESULTS AND DISCUSSION
3.1 | Optimization of the chromatographic
conditions
We optimised a reverse‐phase liquid chromatographic method
for simultaneous estimation of PCB 77 and PCB 180 in mouse plasma
samples using diode array detection. LC method development was car-
ried out focusing on achieving sufficient resolution of target drugs and
endogenous interferences inmatrixwithin a short run time. Themethod
is novel and additionally has certain unique advantages over previously
usedmethods for quantification of chlorinated biphenyl pollutants. First
this method has optimum sensitivity in determination of PCB levels in
mouse plasma with sparse samples. Adequate specificity has also been
4 of 6 RAMANUJAM ET AL.demonstrated in this method for detection of PCB 77 and PCB 180
using an internal standard which has intermediate chemistry.
The method was developed and optimized using a mobile phase
with simple composition and a reverse‐phase column. The mobile
phase and solvent usage are cost‐effective compared with the gas
chromatography employed elsewhere, and the run time is less time
consuming such that a number of samples can be estimated quickly
in the prescribed time duration. The method is also simple and
can be used for rapid estimation of these congeners in plasma samples
during experimental sampling procedures. Finally, the fact that this is
one of the first reports of a rapid simultaneous method that has been
developed and successfully optimized for quantification of two distinct
PCB congeners in plasma cannot be overemphasized.
3.2 | Carry‐over and limit of quantification
No carry‐over was observed when the highest calibration standard
was analyzed just before the blank plasma. This indicated that
flow through needle configuration of the injector and the washing step
of the column at the end of the chromatography separation were
adequate to remove potential residues of the analytes. The LOQ on
the calibration curve was 10.0 ng/mL for all of the compounds and
the signal‐to‐noise ratio in plasma was ≥10.
3.3 | Selectivity and specificity
Selectivity was evaluated by comparing the chromatograms of pooled
plasma and pooled plasma spiked with IS with analytes (10 ng/mL) and
IS. A kinetic study sample was obtained after 4.0 h of inhalation at a
dose of 4mg/m3 (PCB 77 and PCB 180). As shown in Figure 1, no
interfering peaks from endogenous compounds were observed at the
retention times of analytes and IS. The total chromatographic run time
was 6min.
3.4 | Recovery
Liquid–liquid extraction technique gave adequate recovery and clean
samples. The results of the evaluation of neat standards vs plasma
extracted standards were estimated for PCB 77 and PCB 180 (30,
500 and 2250 ng/mL) and the mean recoveries were 90.10 ± 1.34and 89.51 ± 1.52%, respectively. The recovery of IS at 5 μg/mL con-
centration was 87.11 ± 2.70%.3.5 | Linearity
The calibration curves exhibited excellent linearity with regression cor-
relation coefficient (r2) >0.996 over the concentration range of 10–
3000 ng/mL for all of the drugs in mouse plasma. The standard calibra-
tion curve had a consistent reproducibility over the standard concen-
trations across the calibration range. A typical regression equation
was prepared by determining the best fit of peak‐area ratio (peak area
analyte/peak area IS) vs concentration, and fitted to y =mx + c using a
weighting factor (1/x2). The lowest concentration with the RSD <20%
was taken as the LLOQ and was found to be 10.0 ng/mL for the PCB
77 and PCB 180. The percentage accuracies observed for the mean
of back‐calculated concentration for four calibration curves for the
entire drugs were within 96.10–102.50%.3.6 | Accuracy and precision
Accuracy and precision of the method evaluated intra‐day
(repeatability) and inter‐day (intermediate) for mouse plasma for all of
the drug samples are summarized in Table 1. The intra‐ and inter‐day
precisions were <4.64% and the accuracy ranged from 98.90 to
102.33% at all levels. All of the values were within the accepted range
and the method was accurate and precise.3.7 | Stability
The stabilities of PCB 77 and PCB 180 in mouse plasma were investi-
gated under a variety of storage and process conditions, in plasma at
room temperature for 9 h, in the autosampler for 24 h at 15°C, after
three freeze–thaw cycles and after long‐term storage at −80°C for
30 days, and are summarized inTable 2. The results indicated that PCB
77 and PCB 180 were stable under the conditions described above.3.8 | Applicability of the validated method
In this study, we report a rapid simultaneous liquid chromatographic
method for quantifying PCB 77 and PCB 180 in mouse plasma. ForFIGURE 1 Representative UPLC
chromatograms of polychlorinated biphenyl
(PCB) 77, PCB 180 and IS in mouse plasma. (a)
blank plasma sample; (b) blank plasma sample
spiked with IS; (c) blank plasma spiked with
analytes (10 ng/mL) and IS; and (d)
pharmacokinetic plasma samples collected
from mice at 4.0 h time point following
inhalation exposure to PCBs
TABLE 1 Intra‐ and inter‐day precision and accuracy of polychlorinated biphenyl (PCB) 77 and PCB 180 in mouse plasma
Nominal
concentration
(ng/mL)
Intra‐day (n = 6) Inter‐day (n = 18)
Measured concentration (mean ± SD, ng/mL) CV
(%)
Accuracy
(%)
Measured concentration (mean ± SD, ng/mL) CV
(%)
Accuracy
(%)
PCB 77
10.89 10.77 ± 0.50 4.64 98.90 10.83 ± 0.25 2.31 99.45
31.12 31.10 ± 0.39 1.25 99.94 30.98 ± 0.38 1.23 99.55
497.88 493.88 ± 5.56 1.13 99.20 494.21 ± 7.74 1.57 99.26
2243.52 2265.67 ± 7.24 0.32 100.99 2295.72 ± 3.40 2.32 102.33
PCB 180
11.00 10.95 ± 0.21 1.92 99.55 11.16 ± 0.27 2.42 101.45
31.43 31.46 ± 0.62 1.97 100.10 31.32 ± 0.40 1.28 99.65
502.94 503.07 ± 5.00 0.99 100.03 502.15 ± 4.60 0.92 99.84
2266.32 2283.80 ± 6.21 1.39 100.77 2257.64 ± 9.74 0.85 99.62
TABLE 2 Stability of PCB 77 and PCB 180 in mouse plasma under different conditions (n = 6)
Nominal
concentration
(ng/mL)
Bench‐top (room temperature
for 9 h) Autosampler (8°C for 24 h) Freeze–thaw cycles
Long‐term stability (−80°C for
30 days)
Measured concentration
(mean ± SD, ng/mL)
Bias
(%)
Measured concentration
(mean ± SD, ng/mL)
Bias
(%)
Measured concentration
(mean ± SD, ng/mL)
Bias
(%)
Measured concentration
(mean ± SD, ng/mL)
Bias
(%)
PCB 77
31.12 31.51 ± 0.65 −1.25 30.79 ± 0.54 1.06 31.46 ± 0.82 −1.09 31.10 ± 0.70 2.54
2243.52 2267.05 ± 2.84 −1.05 2221.77 ± 5.45 0.97 2276.17 ± 3.27 −1.46 2225.60 ± 9.24 0.80
PCB 180
31.43 31.89 ± 0.47 −1.46 31.09 ± 0.50 1.08 31.71 ± 0.64 2.55 30.99 ± 0.54 1.40
2266.32 2323.15 ± 9.90 −2.51 2257.08 ± 8.75 0.41 2289.96 ± 6.57 −0.89 2300 ± 5.28 −1.52
FIGURE 2 Mean plasma concentration–time profile of PCB 77 and
PCB 180 in mouse plasma after inhalation of PCBs at 4mg/m3 dose
RAMANUJAM ET AL. 5 of 6PCB 77, the AUC0–inf was 2640.37 ± 300.92 ng h/mL, as compared
with 4855.76 ± 733.19 ng h/mL for PCB 180. Similarly, the AUC0–t
was 2387.12 ± 280.64 ng h/mL for PCB 77 which is less than the value
of 3761.24 ± 375.65 ng h/mL obtained for PCB 180. The Cmax for PCB
77 was 231.76 ± 37.90 ng/mL. The Cmax for PCB 180 was greater as
compared with that of PCB 77, which was 369.47 ± 43.24 ng/mL.
The Tmax for PCB 77 was 4 h, which was twice that for PCB 180. Thehalf‐life of elimination of PCB 77 from plasma was 14.11 ± 1.94 h,
which was less than the value obtained for PCB 180, i.e.
19.34 ± 7.26 h. The profile of mean plasma concentration of PCB 77
and PCB 180 vs time is shown in Figure 2.4 | CONCLUSION
A simple, sensitive, and reliable UPLC method has been developed and
validated for simultaneous determination of PCB 77, and PCB 180 in
mouse plasma. This UPLC method has significant advantages, including
good resolution between peaks and adequate extraction recovery
with shorter chromatographic run time. The current method has been
optimized for estimation of PCB congeners of diverse chemical proper-
ties, with high precision and accuracy. It is also highly cost and time
effective, while not compromising the recovery and yield. We have
developed a quick and reliable method to estimate PCB congeners in
mouse plasma samples, which could be applied in regular measurement
of these pollutants in occupational hazard risk assessment. Finally, this
method is comparable to if not better to gas chromatographic methods
reported previously, in terms of analytical validity and practicability.
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